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I. INTRODUCTION 
Worldwide cancer epidemiology indicates that some 80% of all human tumors 
probably have their origin in dietary and environmental factors of a chemical nature 
(1-3). The widespread environmental pollutants, polycyclic aromatic hydrocarbons 
(PAHs), constitute one of the largest and most potent classes of chemical 
carcinogens. PAHs are found in various petroleum and combustion products 
derived from heat and power generation, motor vehicle exhausts (4), and pyrolysis 
of organic matters such as tobacco smoking and certain procedures of food 
preparation. In the United States, estimates of the total annual emission of 
benzo[a]pyrene (BaP) (Figure 1), one of the most widely studied potent 
carcinogenic PAHs, range from 900 tons (4) to about 1300 tons (5). In addition to 
their widespread environmental prevalence, the important role that PAHs potentially 
play in human cancer is also implicated by their relatively high tumorigenic 
potency and their capability of selectively inducing diverse tumors in animal 
tissues, including mammary carcinoma, leukemia, sarcoma, etc. (6). Studies on 
several typical PAH compounds, and in particular BaP, have contributed largely to 
our present knowledge of the molecular mechanisms underlying PAH-induced 
carcinogenesis (1, 7), 
A. Mechanistic Studies of Chemical Carcinogenesis 
Chemical carcinogenesis is generally considered a multi-step process 
emanating from a single somatic cell. One of the key events in the initiation of 
chemical carcinogenesis involves a genetic damage — the formation of DNA-
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Figure 1. Structures of benzo[a]pyTene, l-oxiranylpyrene (1-OP), (+)- and (-)-anti-
BaP diol epoxides ^PDE), (+)-, and (-)-syn-BPDE, benz[a]anthracene 
anti-diol epoxide, and 3-methylchol-benz[a]anthracene (3-MC) anti-diol 
epoxide 
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carcinogen adducts. The damage is permanently fixed as a mutation following cell 
replication. In the case where the formation of the adducts at one or more 
particular sites in DNA triggers proto-oncogene's' expression (oncogenes), the 
• damaged cell will be transformed into a tumor cell (8). Under the proper set of 
circumstances, the transformed cell may escape the nomial cellular controls, 
proliferate, and eventually lead to cancer. This mechanism is supported by a 
variety of experiments which found that the initiation event of carcinogenesis 
induced by PAHs involved specific modification of proto-oncogenes to active 
oncogenes (9). For example, the experiments found that anti-BPDE (Figure 1), the 
ultimate carcinogenic metabolite of BaP, could induce a series of point mutations, 
predominantly GC —> TA and AT —» TA base substitutions, in codons 61 and 12 
(corresponding to glycine (Gly(CGC)) of the Ha-ras proto-oncogene (10). 
Modification in vitro of a plasmid containing the c-Ha-ras proto-oncogene with 
anti-BPDE and subsequent transfection of the plasmid into NIH 3T3 cells generates 
a transforming oncogene (II). In a recent study, exposure of diploid human 
fibroblasts in culture to racemic anti-BPDE induces a mutation in codon 12 of the 
Ha-ras proto-oncogene yielding a GC TA transition (12). The Ha-ras oncogene 
and an as yet unidentified oncogene were shown to transform the fibroblasts. 
Polycyclic aromatic hydrocarbons are chemically stable, water insoluble 
compounds and, as such, are inactive as tumor initiators. Therefore, conversion of 
PAHs to reactive metabolites is a necessary condition in the initiation of cancer 
^ Proto-oncogenes are normal and highly conserved genes controlling 
essential cellular functions like proliferation and differentiation. 
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(13-15). The metabolism of PAHs in a single somatic cell occurs primarily through 
monooxygenation pathways and is catalyzed by the mixed-function oxygenase 
enzymes, like cytochrome P450s (16). The major metabolites are relatively 
• unstable arene oxide intermediates which rearrange spontaneously to phenols. The 
more stable arene oxide metabolites survive sufficiently long to undergo hydration 
catalyzed by epoxide hydrase to yield /ran^-dihydrodiols or to add glutathione 
catalyzed by glutathione-S-transferase. Further oxidative metabolism of the phenols 
and dihydrodiols yields quinones, diol epoxides, and other products (17). Extensive 
studies on the tumorigenic activity in animals have led to the conclusion that the 
bay region diol epoxides are the most reactive and biologically active of all of the 
given PAH metabolites (14, 15, 18-20). 
The prototype of a "bay region" in a PAH is the sterically-hindered region 
between C-4 and C-5 of phenanthrene, and additional aromatic rings may be fused 
to the aromatic nucleus. The bay region epoxides on tetrahydrobenzo rings of PAH 
are characterized by this structural feature. Perturbational molecular orbital 
calculations were applied to the opening of the epoxide to form a resonance-
stabilized carbocation in the bay region (21). In the case of BaP, this corresponds 
to carbocation formation at position 10 (Figure 1). The relative ease of this ring 
opening is characterized by a parameter, AE/P, describing the energy stabilization 
of the carbocation relative to its precursor. It was found that the bay region 
epoxides of a given parent PAH had greater stabilization of the carbocation than an 
epoxide at a non-bay region position. Furthermore, a correlation was established 
between high AE/p values at bay region positions and strong carcinogenic potency 
of various PAH (21, 22). The bay region theory is supported by a lot of 
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experimental evidence that whatever situations favor the formation of more bay 
region diol epoxides, the carcinogenicity of the PAHs will be greatly enhanced. A 
good example is based on co-existing carcinogen effects. When rat liver nuclei 
" were incubated with BaP in the presence of a NADPH-generating system, the major 
metabolites were 9,10-, 4,5-, and 7,8-dihydrodiols, the 3,6- and 1,6-quinones, as 
well as 3- and 9-phenols. By prior administration of 3-methycholanthracene (3-
MC) to the rat, the total nuclear mutagenicity could be stimulated 11-fold. The 
major metabolites yielded were characterized as bay region diol epoxides of 
benzo[a]pyrene (BPDE) (23). As a matter of fact, the binding of BPDE to cellular 
DNA is believed to be a critical event in the initiation of tumorigenesis and 
mutagenesis (23-26), which has lead to great effects to elucidate the mechanism of 
interaction of BPDE with DNA. 
Stopped flow kinetic measurements indicate that the reaction of BPDE with 
DNA are consistent with a mechanism involving initial rapid intercalation 
(complete in < 5 ms) of the diol epoxide between the base pairs of DNA (27). The 
experimentally-observed pseudo first-order rate constant increases in the presence of 
DNA (28, 29). This enhanced reactivity is also a result of the formation of 
physical BPDE-DNA complexes. The intercalated complex was observed to 
undergo rate-determining protonation (~500 sec) to yield an intercalated triol 
carbonium ion intermediate in light that the process is catalyzed by specific and 
general acid (30, 31). Ninety percent of the intermediate is then hydrolyzed to 
yield tetraols which are also physically associated with DNA. The minor part 
forms covalently bounded adducts. The whole process can be illustrated by the 
following reaction scheme (32): 
6 
BPDE + DNAe 
k kg 
[BPDE - DNA] ^ [BPDE^ • DNA] 
(PC) 
BPT •I I kc 
BPT Covalent adducts 
Here, two important parameters are directly related to carcinogenicity and 
mutagenicity of a given PAH. The first is the equilibrium association constant, 
K=kj/k2, which is used to measure the extent of the intercalative diol epoxides with 
DNA. Another parameter is fç^^, which represents the percentage of PAH 
molecules that bind covalently to DNA. A close relationship between the 
carcinogenicity of PAHs and their facility of reaction with DNA can be revealed by 
several model systems (33). A typical example is 3-MC anti-diol epoxide (Figure 
1). Studies of the reaction of 3-MC-anti-diol epoxide with DNA show that both the 
mechanism of reaction and the structures of the adducts formed closely resemble 
those of anti-BPDE (34), but the reactivity of these two diol epoxides is quite 
different. K and the overall rate constant for the reaction (kg) are both about one-
fourth those of anti-BPDE, whereas the extent of covalent binding (f^^y) is almost 
triple that of BPDE. Since 3-MC is a more potent carcinogen than BP, these 
observations suggest that fç^^ relates more to carcinogenicity than either K or kg. 
However, some abnormal phenomena are also observed. The carcinogenicity of 
some PAHs exhibits a significant difference although they have a similar extent of 
covalent binding, for example, the synthetic BPDE analogue 1-OP (Figure 1) has 
similar values of K and f^^^, while it is a weak carcinogen (35). Another example 
is the BA diol epoxide (Figure 1). The BA diol epoxide reacts with DNA by a 
similar mechanistic pathway to anti-BPDE. The values of K and kg are also very 
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similar, but its value is much higher. Unexpectedly, BA is a weak carcinogen. 
These observations implicate that in addition to the extent of covalent binding of 
the diol epoxide, other factors are also able to make a significant contribution to the 
- mutagenicity and carcinogenicity of a given PAH. A variety of experiments and 
reasons have led to speculation that the spatial orientation of the aromatic moiety at 
the covalent binding sites (36), and the structure and the conformation of the PAH-
DNA adducts are crucial for the carcinogenic effects (17, 32, 33, 37). 
Spectroscopic studies of structures and conformation of BPDE-DNA adducts 
provide a key to understanding these mysterious factors. 
Extensive spectroscopic studies have shown that the structures of the covalent 
adducts formed by anti-BPDE with DNA are of two types, designated "site I" and 
"site n." Site I adducts are characterized by a 10 nm red shift in the ultraviolet 
absorption spectrum and a negative linear dichroism spectrum (LD). Therefore, site 
I appears to involve intercalation or partial intercalation of the pyrenyl chromophore 
between base pairs of the DNA. The site n adducts exhibit a positive LD and a 
small 2-3 nm red shift in the UV region, and therefore, have an externally bound 
conformation with the aromatic moiety residing in the minor groove with its long 
axis inclined at an angle of ~35° to the DNA helix (17). (-)-anti-BPDE-DNA 
adducts are heterogeneous and consist of about 2/3 site I and 1/3 site 11 adducts 
(38); in contrast, the majority of (+)-ani-BPDE-DNA adducts (90%) are of the site 
n type. Since (+)-anti-BPDE-DNA adducts are potent carcinogens, type II adducts 
are assumed to be mainly responsible for their potent carcinogenicity. This 
mechanism can explain why 1-OP and BA diol epoxide are weak carcinogens since 
both of them were found to form predominantly type I adducts. 
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The studies of the interaction of BPDE with DNA have contributed largely to 
our present knowledge of the molecular mechanisms underlying PAH-induced 
carcinogenesis. However, several problems still remain unclear. 1) The LD 
experiment is not able to distinguish the physically intercalated BP tetraols and 
covalently intercalated adducts. In addition, UV absorption cannot determine if a 
small amount of free BPT exists, since its absorption peak is almost overlapped 
with that of site n adducts. 2) The absorption and LD spectrometries do not have 
sufficient sensitivity to study in vivo systems when the adduct level is very low. 3) 
Earlier studies with the mutagenic and carcinogenic alkyl-nitrosoureas have shown 
that minor products of DNA reactions are largely responsible for the biological 
effects of these molecules, and similar situations may apply to the PAHs (24). This 
argument is further supported by the results of the carcinogenic studies of 7,12-
dimethylbenz[a]anthracene (DMBA) (39, 40). In addition, recent experiments 
found that the binding of anti-BPDE to dA might be an important factor to initiate 
a tumor in mouse skin (41). Previous studies using digested adducts have found 
that (+)-anti-BPDE is almost exclusively bound to the N^-dG position (94%) (36), 
while the covalent (-)-anti-BPDE-DNA adducts formed in vitro consists of 58% N^-
dG-BPDE, 21% 0®-dG-BPDE, and 18% N^-dA-BPDE (24, 36). These different 
adducts are expected to manifest themselves by their different spectra. But the UV 
absorption and LD spectra of (-)-anti-BPDE-DNA cannot discern these adducts and 
only show a broad band with a maximum around 343 nm for all type II adducts. 
Fluorescence decay experiments did not exhibit much difference either, and even 
worse, they could not reveal if the adducts detected correspond to site I or n (38). 
Therefore, in carcinogenic studies it is important to develop highly selective and 
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sensitive bioassay methods to determine how many types of site I and site H 
adducts exist, and to assign die chemical origin of the adducts detected. Solutions 
to these problems will shed light on the understanding PAH interactions with DNA. 
B. Studies of Carcinogenesis in Environmental Monitoring Using Fish 
Exposed to Chemical Carcinogens 
The concern over contamination of the estuarine and coastal environments in 
the world has led to great efforts to evaluate the relationships between contaminant 
exposure and observed biological effects in aquatic organisms. For example, two 
tributaries of the Great Lakes, Buffalo River and Detroit River, are extensively used 
for drinking water. Field assays found that both of them were heavily contaminated 
by PAHs. In several PAH-contaminated areas of the Buffalo River, levels of 15 
individual priority pollutant PAHs ranged from 0.5 to 17 mg/kg in sediments, with 
BaP being 3.1 mg/kg (42). In the Detroit River, levels of individual PAHs ranged 
from 0.1 to 38.8 mg/kg, with BaP levels ranging from 0.1 to 17.6 mg/kg in 
different samples (43). The concern was further underscored when spontaneous 
tumors were found in a variety of fish species from both freshwater and marine 
environments. For example, English sole and rock sole exhibit a high frequency of 
liver cancer when sampled from chemically-polluted estuaries in Puget Sound, WA 
(44, 45). Winter flounder in Boston Harbor, MA and brown bullhead in Niagara 
River, NY also show a high incidence of liver neoplasia (42). The freshwater drum 
captured from areas in eastern Lake Erie and the Niagara River had developed 
dermal neoplasms on their flanks (42), Moreover, in laboratory studies brown 
bullhead painted with river sediment extract were found to undergo a series of 
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localized skin changes and eventually to develop multiple skin papillomas, which 
indicate that PAHs are responsible for cancer found in the fish (42), As early as 
1964, Dawei et al. hypothesized that bottom-dwelling fish species exhibit increased 
frequencies of neoplasms and thus, may serve as early warning indicators of 
carcinogenic hazards to man (46). This argument is further supported by the study 
which found that the repair mechanism of some fish is relatively inefficient (47, 
48), and thus, an evaluation of the fish DNA-adducts may reflect the genuine 
initiation processes of chemical carcinogenesis. However, some bottom fish species 
do not show a high prevalence of cancer. Starry flounder, from Puget Sound, WA, 
exhibits only a low frequency of liver cancer (49). The dissection of thousands of 
carp from several contaminated areas did not find any obvious propensity for 
neoplasm development (50). In addition, laboratory studies with salmonid fish have 
demonstrated that the Mount Shasta strain of rainbow trout is susceptible to both 
BaP and aflatoxin induced cancers, whereas coho salmon is relatively resistant 
to these carcinogens (51, 52). As many xenobiotics exert their carcinogenic effects 
only after metabolic activation, detailed studies on the activation and detoxication 
of carcinogens in various fish may provide valuable insights into whether there is a 
biochemical basis for the differences among fish species in their susceptibility to 
chemical carcinogens. 
Our research focused on the study of the metabolic activation of PAH in the 
liver tissues of English sole because this species exhibits a high prevalence of liver 
neoplasms in several PAH-contaminated areas (44, 45, 53). The significance of this 
study is further emphasized by the finding that long-term exposure of English sole 
to BaP results in a spectrum of toxicopathic lesions similar to those observed in 
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fish captured firom contaminated areas (54). Enzymatic hydrolysis and analysis by 
reversed-phase HPLC of hepatic DNA isolated from English sole exposed to 
radiolabeled BaP, however, did not show the presence of detectable levels of 
BPDE-DNA adducts (55). A recent study (56) using English sole hepatocytes 
exposed to ^H-BP showed no detectable BPDE-dG adducts. The adduct level in 
this in vivo fish sample is apparently very low, and highly sensitive bioanalytical 
techniques are imperative in this study. The second fish sample we investigated is 
caip captured from a heavily PAH-contaminated area of the Buffalo River. Since 
carp are not found to develop neoplasia when exposed to heavily PAH-
contaminated areas, the study of this project attempts to determine what kind of 
adducts can be formed in fish, and the detailed features of the adducts (e.g., 
conformation and stereochemical structures, etc.). Apparently, it is significant to 
characterize the adducts, to reveal the chemical origins of exposure. But the 
determination of the conformations and stereochemistry of the DNA adducts is also 
of particular importance, since in the case where the DNA adducts are detected in 
the carp and English sole, the specific features of the adducts could explain why 
these two fishes exhibit quite different carcinogenicity. 
C. Studies of Chemical Carcinogenesis in Human System 
Since PAHs are widely distributed throughout the atmosphere and water 
sources in the world, it is almost impossible to avoid exposure to nanogram 
quantities of these substances on a daily basis (1-3). Chemical carcinogens and co-
carcinogens are considered to be responsible for many human cancers (57). 
Therefore, it is very significant to study the biological effect of man's exposure to 
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the numerous chemical compounds, the mechanism by which these compounds 
exert their deleterious effects in exposed subjects, and the overall consequences of 
such exposure. The placental tissue is a potentially important source of material for 
molecular epidemiological studies in light of several experimental observations (58). 
For example, cigarette smoking and exposure to cooking oil contaminated with 
polychlorinated biphenyl and their thermal degradation products are known to 
strongly induce cytochrome P-450-related monooxygenase activity in human 
placenta. This suggests that this tissue is able to activate metabolically a variety of 
chemical carcinogens and is highly responsive to effects of environmental exposures 
(59-61). Studies in experimental animals showed that transplacental exposure to 
several classes of known carcinogens can cause cancer in adult animals (62, 63). 
Consideration of the extraordinary difficulties implicit in using traditional 
epidemiologic approaches to study prenatal determinants of disease in adult life 
suggests a need for developing new approaches to the identification of potential 
human transplacental carcinogens (58), Moreover, a large quantity of tissue 
available facilitated replicate analyses of each specimen by several assays for DNA 
adducts and could potentially be used for additional assays studying the 
relationships between levels of adducts and such factors as metabolic activity or 
differences in DNA repair. 
Previous experiments using ^^P-postlabeling assay detected the presence of a 
DNA adduct in the human placenta which was strongly associated with maternal 
smoking during pregnancy (64). This adduct was also found to be related with 
maternal smoking for a larger study population (58). Recently, both ^^P-
postlabeling assay and ELISA (using antibodies to chemically-modified DNA in 
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enzyme-linked immunosorbent assay) have been successfully used to detect 
carcinogen adducts in women's placental DNA samples (65). A total of seven 
different adducts were detected in 53 subjects, and three of these adducts were 
- found almost exclusively in smokers. Among smokers, there were positive dose-
response relationships between levels of the smoking-related adducts and 
biochemical estimates of doses of maternal exposure to cigarette smoke during 
pregnancy. In addition, levels of smoking-related adducts were inversely associated 
with the birth weight of offspring. Everson and co-workers (65) observed by 
ELISA that the antibodies modified by anti-BPDE have a positive response to the 
placenta adducts regardless of whether the person smoked. Since other adducts 
formed from anti-benz[a]anthracene diol epoxide and anti-chrysene diol epoxide 
also reacted with the antibodies (64, 66, 67), they could not verify that the placenta 
DNA contained anti-BPDE-DNA adducts. To date, neither the chemical origin of 
the adducts nor their precise structures have been determined, and the exposure or 
susceptibility factors that are most closely associated with biochemical or molecular 
damage to human tissues are still a mystery (65). Besides, characterization of the 
DNA adducts formed from the specific stereoisomer of a chemical carcinogen in 
human tissues is also of particular significance, since different stereoisomers of a 
chemical carcinogen can have quite different mutagenicities and tumorigenicities 
(17, 33). Hence, further studies of carcinogenesis in humans require highly 
selective and sensitive assay techniques which not only detect very low adduct 
levels (pmol to fmol), but also characterize the chemical origins and specific. 
stereochemistry of the adducts as well. 
14 
n. FLUORESCENCE LINE NARROWING SPECTROSCOPY (FLNS) 
A. Principles of FLNS 
Prior to the following discussion, we point out that some experimental 
conditions are met. First, the concentration of the molecules of interest is low 
enough (usually < 10"^ M) to neglect all interaction between them; second, the 
temperature is also sufficiently low (< 30 K) to minimize the effects of the thermal 
broadening; and third, the electronic excitations of the solvent lie at higher energies 
than the lowest excited singlet state (Sj) of the analyte molecules so that the 
selective excitation of the molecule is possible. Since the theory of FLNS has 
previously been discussed in great detail (68, 69), only a brief discussion will be 
given here. 
In an amorphous host matrix such as a glass, the inherent structural disorder 
leads to energetic inequivalence of different analyte sites. As a result of the 
differing local electrostatic fields, a distribution of narrow homogeneous absorption 
bands due to the individual sites are formed. The broad absorption profile created 
is known as a site inhomogeneously-broadened absorption profile, and it is in the 
case of inhomogeneous broadening that the FLN phenomenon is possible. Figure 
2A shows a site inhomogeneously-broadened absorption profile which is actually an 
ensemble of a very large number of individual site absorptions possessing a 
homogeneous linewidth At liquid helium temperature (T = 4.2 K), ^ 
0.1 cm*' for the 0-0 transition, while for the broadened absorption profile, the 
bandwidth ^ 100 cm"'. FLNS is a member of the class of spectral line 
narrowing spectroscopies and, as such, has the ability to eliminate or greatly 
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diminish the contribution of inhomogeneous-broadentng to the fluorescence vibronic 
bandwidth. By exciting into the inhomogeneously broadened absoiption band with 
a narrow line excitation source, only those sites with absorption profiles that 
overlap the excitation line will be excited. Provided that intersite conversion 
processes (e.g., due to intermolecular energy transfer) do not occur in the time scale 
of the fluorescence, only the initially excited sites (isochromats) wiU fluorescence. 
The resultant spectrum consists of a series of greatly narrowed bands (called zero-
phonon lines, or abbreviated as ZPL) corresponding to the fluorescence emitted 
from the initially excited isochromat. The width of a vibronic ZPL is ~ 2 cm"'. 
The effect of the inhomogeneous broadening is thereby reduced, and the narrow-
line fluorescence serves as the basis for a qualitative and quantitative methodology 
for fluorescing molecules (68, 69). 
An interesting complication to the above picture is provided by the.coupling 
between the vibronic states of the analyte molecule and the phonons of the host 
medium (electron-phonon coupling). This coupling manifests itself by the 
appearance of a phonon sideband (PSB) which builds on the ZPL. For the 
fluorescence spectrum, the PSB is located on the lower energy side of the ZPL 
(Figure 2B). In glasses, the PSB due to one-phonon creation is typically broad (~ 
30 cm"'). The ratio of the integrated intensities of ZPL (I^pl) and PSB (Ipse) is 
given by the Debye-Waller factor a (68), 
- Izpl/^^ZPL ^PSB) (1) 
Taking into account the absorption process which leads to fluorescence, it can 
be shown that the observed Debye-Waller factor in fluorescence, a', is 
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approximately equal to the product of the and (68), for example, 
a' = «absOn 
= ( 2 )  
Since to a first qjproximation, = Ojj s a. 
Under the linear approximation for electron-phonon coupling, the Debye-
Waller factor can be expressed by a simplified equation which takes into account 
the temperature dependence (68); 
a(T) = exp [- j^(v)[2(e''/kT i)-i+i]dv j (3) 
Here, ^(v) is the weighted density of phonon states given by equation (4): 
yv)= 6N^V)p(v) (4) 
Where, p(v) is the phonon density of states of the host, N is the number of 
impurity molecules, and ^(v) is the linear electron-phonon coupling constant. 
The approximate relations (1-4) indicate that the general appearance of the 
fluorescence spectra upon selective excitation significantly depends upon the 
quantity a, and the host medium plays an important part in the solid state 
spectroscopy of a molecule. If the coupling between the vibronic states of the 
molecule and the phonon state of the host medium is veiy strong, the value of a 
will be greatly reduced. Under this circumstance, the fluorescence of non-
resonantly-excited centers which absorb via their PSB will dominate and the ZPL 
intensities will be diminished. That is, the PSB will dominate the fluorescence 
spectrum. For example, for a Debye-Waller factor a = 0.05, and a'.= 0.0025, it 
would be difficult to detect the ZPL in the spectrum (68). In addition, temperature 
has a pronounced effect on the relative intensities of the ZPL and PSB. 
17 
Figure 2. A. Inhomogeneous broadening of an absorption profile in a glassy 
matrix at low temperature (<20 K). The homogeneous (r„oin) 
inhomogeneous (T^) linewidths are indicated. B. The general nature 
of the spectral band of an impurity center 
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According to equation (3) and for a fixed coupling, an increase in temperature will 
lead to a decrease in ZPL intensity and to the "transfer" of the lost intensity to the 
PSB. A good example of this effect has been provided by fluorescence studies of 
perylene dissolved in both polar and non-polar solvents (70). At 4.2 K, the 
spectrum of perylene is dominated by strong ZPL. A marked decrease in ZPL 
intensity accompanies an increase in temperature. Between 40 and 50 K, the ZPL 
practically disappears. 
The features and appearance of a qiectrum are also dependent upon the 
excitation wavelength. The narrow excitation region must be situated within the 
inhomogeneously-broadened absorption profile so as to excite only one or a few 
isochromats belonging to different vibrational states. For high energy vibronic 
excitation of the state (e.g., exceeding the (0,0) transition frequency by 2: 3000 
cm'^), high vibronic levels and corresponding ZPL are considerably broader than 
the purely electronic ones. Furthermore, in this region there is a significant 
increase in the density of states, which results in high congestion of "isochromats" 
belonging to many vibrations. As a result, the laser excites practically all types of 
centers. The pertinent fluorescence spectrum is virtually broad-band. The greatest 
degree of line narrowing will take place, therefore, if excitation is into either the 
origin or low lying vibronic bands of the lowest excited singlet state (S|). For 
origin excitation, the ZPL are generated by the transitions originating from the zero-
point vibronic level of and terminating at the zero-point and vibronic levels of 
SQ. The resonance 0-0 transition line is not a reliable analytical line because its 
frequency coincides with that of the laser line. Therefore, the vibronic transitions 
only provide the ground vibrational frequencies. One of the features of origin 
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excitation is that the variation of the laser frequency within the limits of the 
inhomogeneous broadening (100 to 300 cm'^) in the 0-0 region causes a 
corresponding displacement of the FLN spectram along the frequency scale without 
changing its nature. 
Utilization of vibronic excitation has several advantages over the origin band 
excitation from the standpoints of characterization and selectivity. The improved 
selectivity with vibronic excitation is based upon the fact that the vibronic features 
in SQ absorption spectrum are often more sensitive to structure perturbations 
than the fluorescence spectrum (71, 72). Figure 3 is presented here to 
describe a vibronic excitation scheme. An absorption spectrum in Figure 3A 
includes two overlapping vibronic levels, 1„ and Ip, and a narrow line laser excites 
the two overlapping one-quantum vibronic transitions, (1„,0) and (lp,0). Taking 
the molecule population distribution in each vibronic level into consideration, (O^ 
excites an isochromat associated with Ip that lies close to the most probable 
position (or central position) of its distribution, while that associated with 1^^ lies 
near the top of its distribution. Subsequently, the excited molecules relax within 
picoseconds to the zero-point vibronic level of Sj. Fluorescence then occurs. 
Vibrational relaxation is indicated by the downward wiggly arrows which show that 
fluorescence is due to two different isochromats linked to the two vibronic levels 
initially excited. The fluorescence from the two isochromats results in a doubling 
of the origin as well as the (0,1) vibronic transitions. The resulting fluorescence 
has the appearance of Figure 3B in which the intensity of the p mode transition is 
much higher than that of the a mode transition. 
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An important point is that the energy differences from the laser line to the. 
(0,0) bands are equal to the vibrational frequencies of the molecule in the state, 
while the displacements between the (0,0) and (0,1) bands yield ground state 
frequencies. A slight variation of the laser frequency in the overlapping region of 
Ig^ and Ip will result in the change of relative intensity distribution of ZPL that 
originates from the a and p modes. For instance, if a frequency to l selects an 
isochromat associated with 1^^ that lies close to the most probable position of its 
distribution, the appearance of the fluorescence spectrum will look like Figure 3C 
when a-ZPL are the more intense. By varying throughout the vibronic 
absorption region, it is possible to explore a wide range (~ 400-1600 cm"') of 
active Sj vibrational frequencies. Thus, a great degree of characterization and 
minimization of spectral interferences is possible. 
With the notion of isochromat selection established by FLN, photochemical 
hole burning (PHB) followed logically. It is apparent that if the species giving rise 
to the absorption is photoreactive, isochromats can be photobleached selective (73). 
"Non-photochemical hole burning (NPHB) does not require photoreactivity of 
the absorbing species. What is required is a host with a 'faulty memory' for its 
pre-excitation configuration around the absorber. That is upon completion of the 
ground state -» excited state —> ground state cycle, the host configuration must have 
changed and, more or less, permanently if persistent holes are to be produced". 
(74). Because hole burning processes result in a loss of absorbers at the excitation 
energy, it is important for high sensitivity measurements not only to be aware of 
their possibility but also to be able to minimize such processes where they do 
occur. For example, it has been shown recently that one can minimize the 
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deleterious effects of NPHB by synchronous scanning of excitation and detection 
wavelength, (thus, continuously changing the isochromat excited), by use of a 
slightly higher temperature (10-20 K, which can increase the bleaching time of the 
hole-buming) and by restoring die original inhomogeneous distribution through 
broad band excitation (e.g., using white light to refill the hole) (72). 
Under some circumstances, broad band fluorescence, strong phonon wings, and 
laser and other scattering backgrounds degrade the FLN spectrum so badly that it is 
hard to analyze the spectrum. In such cases, a recently developed methodology 
called double selection FLN-NPHB spectrometry (DSFLNS) can be used to 
circumvent these problems (72). This method takes advantage of the NPHB effect 
and is based on the following three procedures. First, obtain à normal spectrum. 
Second, increase the laser power to bum a large majority of molecules on that site 
and then take a second spectrum. Finally, substract both spectra to produce a very 
nice spectrum with improved detection limits. 
B. Applicability of FLNS to the Study of Chemical Carcinogenesis 
Formation of an adduct between the genetic material DNA and a chemical 
agent is thought to be a crucial step in the initiation of carcinogenesis and 
tumorigenesis (13-15). Since typical DNA damage levels are low (< 1:10® 
adduct:base pairs), there has recently been considerable interest in the development 
of highly sensitive bioanalytical techniques for damage analysis. Equally important 
as high sensitivity is the requirement of high selectivity of the type which allows 
for the distinction between structurally similar DNA adducts. Advantages also exist 
for a technique which is applicable to the intact DNA adduct rather than only to the 
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ideal method for the study of DNA damage should be applicable to small samples 
of DNA with low adduction levels found in real samples (75, 76). Several 
fluorescence-based techniques have been utilized (75, 77-79). In particular, FLNS 
- has become an effective technique for the identification and determination of DNA 
adducts and the study of various metabolic pathways leading to tumor formation 
(72, 80-86). 
The inherent advantage of FLNS is its high selectivity, which is a direct 
consequence of the presence of many narrow lines in the FLN spectra of a given 
molecule (68, 69). Since both the ground and excited state vibrational frequencies 
can be probed utilizing origin (0,0) and vibronic (1,0) excitation, a unique spectral 
characterization is generally possible. FLNS has previously been shown to have 
sufficient selectivity to directly distinguish substitutional isomers of a given PAH, 
polar PAH metabolites, and their corresponding DNA-bound adducts (82, 83, 87); 
for example, BP tetraol and the covalently bound BPDE-DNA adduct, and different 
DNA adducts possessing the same fluorescent chromophore (82, 87). FLNS also 
exhibits sufficient selectivity to analyze the complex mixtures of PAH metabolites 
and PAH-DNA adducts which are likely to be found in real samples (87). Using 
selective excitation and temporal discrimination, FLNS has been shown to be 
capable of directly resolving all the components in a laboratory mixture of five 
DNA adducts, three of which possessed the same fluorescent chromophore, 
phenanthrene (82), and all the components in a mixture of six PAH metabolites and 
two DNA adducts (82, 87). In addition, FLNS was successfully applied to the 
study of the one electron oxidation pathway involved in the metabolic activation of 
BaP in vitro (83, 88). FLNS could distinguish between five BaP-nucleoside 
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adducts synthesized by one electron oxidation of BaP in the presence of guanosine, 
deoxyguanosine, and deoxyadenosine. When FLNS was used to study the 
horseradish peroxidase catalyzed reaction of BaP with DNA, the major adduct 
• identified in this in vitro system was found to be 8-(BaP-6-yl)guanine, a typical 
mono-electron oxidation product. 
It is noted that only a small fraction (~ 10 )il DNA sample (Img/ml)) of the 
sample molecules is sufficient, hence, the sensitivity of FLNS is quite impressive. 
For moderately strong absorbing and fluorescing molecules such as anthracene and 
I-methylpyxene, detection limits of 0.2 pg can be achieved (72). For (+)-anti-
BPDE-DNA when using double selection of FLNS-non-photochemical hole burning 
technique, a detection limit of ~ 3 adducts in 10® DNA bases was reported for a 20 
^g DNA sample (72). 
Perhaps the most valuable attribute of FLNS is the ability to characterize intact 
(i.e., macromolecular) DNA samples. There is no need to chemically or 
enzymatically digest the DNA to nucleotides and isolate the damaged (adducted) 
nucleotides or derivatize the adducts prior to the analysis. The fact that DNA 
digestion can be avoided is important in the sense that less manipulation of the 
DNA is required and, therefore, there is a smaller chance of altering the profile of 
adducts; all adducts formed, including the unstable adducts which can depurinate 
and be lost from the DNA, can, in principle, be detected. Moreover, the fact that 
extensive sample preparation is not required makes FLNS a rapid method of 
analysis. 
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m. EXPERIMENTAL 
A. Materials and Methods 
The solvents and chemicals used were from different commercial sources. 
Electrophoresis purity reagent aciylamide, the fluorescence quencher used, was 
from Bio-Rad Laboratories and was > 99.9% purity. 7,8,9J0-tetrahydro-7,8,9J0-
tetrahydroxy-benzo[a]pyrene (BPT) was obtained from the Midwest Research 
Institute, Kansas City, Missouri, through the NCI depository. Reagent grade 
glycerol (Fisher Scientific Company) and absolute ethanol (100%) (Ames Lab 
storeroom) were used without further purification. The water used to dissolve 
samples was deionized distilled water. A mixture consisting of 5:1 glycerol:ethanol 
(by volume) was used as a glass-forming solvent for the majority of the samples 
analyzed. Calf thymus DNA was obtained from the Sigma Chemical Company and 
repurified by phenol extraction and ethanol precipitation prior to use. DNA 
samples were mixed to form a glass with 50% glycerol, 10% ethanol and 40% 
water, which is optically clear at 4.2 K. DNA samples were dissolved in water to a 
concentration of - 1 mg/ml. These samples were mixed 60:40 with the 
glycerol:ethanol solvent prior to analysis or were analyzed as dissolved. At 4.2 K, 
the DNA-in-water samples were not optically clear, but were FLN-fimctional. 
However, if the sample contains an extra amount of salt (e.g., from buffer 
solutions), a snowing glass will form at the low temperature. The formation of this 
kind of snowing glass could significantly affect the efficiency of the detection, 
since most of the laser beam is scattered without penetrating the sample. In such a 
case, the sample must be desalted to get rid of the majority of the salts in the DNA 
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sample by the following procedure. First, redissolve a dried DNA sample into 100 
|xl distilled water; then, add 2 volumes of ice cold ethanol (- 20 °C) to precipitate 
DNA; leave the sample in the freezer overnight to make sure most of the DNA has 
" been precipitated, then put the precipitated DNA sample in a microcentrifuge 
(Fisher 235B) and spin for 10 minutes at 4 °C; finally, remove the supernatant and 
ethanol. 
Quartz tubing, 3-mm O.D. x 2-mm I D. x 1 cm, sealed at one end, was used 
as the sample container (30 |xl total volume). The smaller sample volume was 
desirable to achieve lower detection limits, and quartz tubes were necessary for the 
ultraviolet excitation and emission wavelengths typically encountered with the 
species investigated. For most of the experiments performed, anaerobic sample 
conditions were needed. The degas procedures were accomplished by a series of 
freeze/pump/thaw cycles prior to completely sealing the tube under anaerobic 
conditions. The sample tubes were.held vertically in an aluminum sample holder 
designed to occlude laser scatter from the sample tube edges and were lowered into 
a liquid helium dewar (2 min total immersion time) for analysis. Two different 
liquid helium dewars were employed: a double-nested 3 L glass liquid helium 
dewar (Pope Scientific) having quartz windows and designed to have no liquid 
nitrogen in the optical pathways and a 5 L glass liquid helium dewar. All FLN 
spectra presented in this dissertation were obtained with the samples at liquid 
helium temperature, 4.2 K. The laser-excited conventional fluorescence spectra 
were obtained at liquid nitrogen temperature, 77 K. 
Room temperature absoiption q^ectra were obtained using a Varian DMS 100 
UV/vis spectrophotometer, and fluorescence spectra were obtained using a Spex 
FluoroIog-2 spectrometer. 
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B. Samples and Preparation 
All of the model compounds, standards, and the DNA samples were supplied 
by our collaborators: Dr. N. E. Geacintov (Department of Chemistry, New York 
University, NY); Dr. U. Varanasi (National Marine Fisheries, Seattle, WA); Dr. A. 
Maccubbin (Grace Cancer Drug Center, Roswell Park Memorial Institute, New 
York State Department of Health, NY); and Dr. A. Jeffrey (Institute for Cancer 
Research, Columbia University, New York, NY). I would like to express my 
sincere gratitude to them for their great support and assistance here. 
The DNA, synthetic alternating (dG-dC) and (dA-dT) polynucleotides, single 
strand dG and dG-dC polynucleotides, d(ATATGTATA) oligomer adducts of (+)-
and (-)-anti-BPDE were provided by Dr. N. E. Geacintov (Department of 
Chemistry, New York University, NY). The synthesis of the two enantiomers of 
(+)- and (-)-anti-BPDE was accomplished by a method described previously (89, 
90). The high molecular weight calf thymus DNA (Worthington Biochemicals, 
Freehold, NJ) was dissolved in 5 mM sodium cacodylate buffer, 0.1 M NaCl, and 3 
mM ethylene diamine tetraacetate and extensively dialyzed against 5 mM sodium 
cacodylate buffer. The hyperchromicity of this DNA (comparison of absorbance at 
260 nm at 25 °C and at 90 °C, 1.1 M NaCl, pH 7.0) was in the range of 38-40%. 
The reaction mixture containing either one of the enantiomers of anti-BPDE 
(3.5x10"*^ M) and DNA (7.6x10"^ M, nucleotide concentration) in a buffer solution 
was incubated at 25 °C, pH 7.0 for 12 hrs. After reaction was complete, the 
physically-bound tetraols were removed by extracting the aqueous phase twelve 
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times with ether, followed by a.precipitation of the modified DNA by a 2.5-fold 
excess of cold ethanol. The DNA was then resuspended in the buffer solution. 
This procedure was repeated with mixtures of tetraol and unreacted DNA; all of the 
physically-bound tetraols can be removed by this technique, thus verifying that this 
method is adequate for isolating only the covalently bound reaction products. The 
similar procedures were used to make the synthetic polynucleotides and oligomer 
adducts. The adduct level measured for (+)-anti-BPDE-DNA is about 0.5% 
modification; for (-)-anti-BPDE-DNA, 1.5%; for single strand poly dG adducts of 
(+)-anti-BPDE, 0.37%; for single strand poly dG adducts of (-)-anti-BPDE, 0.22%. 
The syn-BPDE-DNA and English sole liver DNA samples were obtained from 
Dr. U. Varanasi (National Marine Fisheries, Seattle, WA). [^H]-Syn-BPDE was 
obtained from the National Cancer Institute Chemical repository. Unlabeled BaP 
(B-1760), salmon sperm DNA (D-1626), NADPH (N-1630), RNase (R-4875), and 
sodium dodecyl sulfate (L4509), were obtained from Sigma Chemical Co., St. 
Louis, MO. Phenol (24232-2) was purchased from Aldrich Chemical Co., 
Milwaukee, WI. T4 polynucleotide kinase (#70031) was purchased from the United 
States Biochemical Corporation, Cleveland, OH. All other chemicals used were of 
analytical grade and were used without further purification. 
The BaP was purified by the method of Varanasi and Gmur (91). The DNA 
adduct standards of syn-BPDE were prepared by the addition of 66 nmoles of [^H]-
syn-BPDE in tetrahydrofuran:triethylamine (19:1, v/v) to a solution of 2 mg of 
salmon sperm DNA in 1 ml of distilled water. The solution was incubated at 25 °C 
for 1 hr while being gently stirred and then extracted with nitrogen-sparged ethyl 
acetate (3x1 ml) to remove hydrolysis products of BPDE. The modified DNA 
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was isolated by precipitation with cold ethanol (- 20 °C), dissolved in 0.05 M Tris, 
pH 7.5, to a concentration of 1 mg DNA/ml; and then stored at - 20 °C. The level 
of modification of [^H]-syn-BPDE-DNA, as determined radiometrically, was 
" approximately 1 adduct in 10^ bases. 
English sole were collected by otter trawl from a non-industrialized area of 
Puget Sound, WA and were held ûi flowing seawater (28%o) for up to two weeks 
for acclimation. Fish were fed with a 1:1 mixture of ground clams and krill 
containing gelatin as a binder. Neither PAHs or PCBs were present at detectable 
concentrations in the food. English sole (47±11 g) were injected parenterally in a 
sinus near the fin ray with either 50 mg or 100 mg BaP/kg (by weight (b.w.)); the 
BaP was dissolved in Emulphor 620:acetone (1:1) and administered at 1 ml/kg b.w. 
The second batch of English sole were exposed under controlled laboratory 
conditions to water contaminated with a mixture of dibenz[a,h]anthracene, 
benzo[b]fluoranthene, and BaP. The control fish were given an injection of solvent 
vehicle only. The fish were not fed during the 24 hr period preceding sampling to 
insure that bile would be present in the gall bladder when the English sole were 
sampled. The liver was sampled fi"om English sole from all dose groups at one day 
post-exposure. The liver samples were immediately frozen in liquid nitrogen and 
then stored at - 80 "C. 
Hepatic DNA was isolated using the method of Bender et al. (92) with slight 
modifications. A sample of liver (50-100 mg) was homogenized in 1 ml of grinding 
buffer (100 mM Tris-HCl, 100 mM sodium chloride, 50 mM EDTA, 200 mM 
sucrose, 0.5% SDS, pH 8.0-8.2) using a Bounce homogenizer. The homogenate 
was transferred to a 1.5 ml Eppendorf micro-centrifuge tube and incubated at room 
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temperature for S min, followed by the addition of 250 pi of 5 M potassium 
acetate. The sample was then gently vortexed and incubated on ice for 30 min. 
Precipitated protein was pelleted by centrifugation for S min at 16,000 x g in an 
Eppendorf centrifuge (Model 5412). The clear supernatant was extracted 
sequentially with phenol (containing 0.1% 8-hydroxyquinoline) and 
chloroform:iso-amyl alcohol (24:1, v/v). DNA was precipitated with 100% ethanol 
and washed once with 70% ethanol. After drying for 1 hr, the DNA was dissolved 
in 300 pi TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 7.5) and 10 pg of RNase 
A was added. The solution was incubated at 37 "C for 30 min, after which 175 pi 
of 7.5 M ammonium acetate were added. DNA was precipitated with 100% ethanol 
and incubated on ice for 10 minutes. The purified DNA was washed with 70% 
ethanol and subsequently dissolved in 75 pi of TE buffer. The concentration of 
DNA in solution was determined from A2gQ using an extinction coefficient of 22.9 
ml/mg-cm. 
The modification of salmon sperm DNÀ by BaP in vitro was done using 
hepatic microsomes from control English sole prepared according to Schnell et al. 
(93). The reaction mixture consisted of microsomes (0.2 mg/ml), DNA (2 mg/ml), 
2.5 pM BaP, 1 mM NADPH, 50 mM Tris buffer, pH 7.5, in a total volume of 2 
ml. The reaction was initiated with the NADPH and was run at 25 °C for 30 min. 
DNA was isolated from the reaction mixture by two extractions with 
chloroform:iso-amyl alcohol (24:1, v/v), followed by precipitation with two volumes 
of cold ethanol. 
The liver DNA samples of fish from polluted areas were prepared by Dr. 
Alexander Maccubbin (Grace Cancer Drug Center, Roswell Park Memorial 
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Institute, New Yoric State Department of Health, NY). The carp were collected 
from one of the polluted Great Lakes tributaries, Buffalo River, by electroshocking. 
The carp were obtained from a point approximately 1 km from the mouth of the 
river. They were compared with aquarium-raised fish of a similar or slightly lower 
age which had been ce^tured from a shallow non-industrialized land locked pond 
and then maintained in clean aquarium at the Roswell Park Memorial Institute. 
Aquarium fish were fed a commercial trout diet and had been in the aquarium for a 
minimum of 6 months before sampling. Livers were removed from the fish, and 
the small (approximately 0.5 g) pieces were frozen in dry ice and were maintained 
in dry ice or at - 70 °C until the DNA was extracted. Pieces of liver, 100-200 mg, 
were diced with scissors into pieces 1 to 2 mm large, and were digested for 3 hr at 
37 °C in 0.7 ml SET buffer containing 0.5% sodium dodecyl sulfate and 1 mg/ml 
proteinase K. Samples were then deproteinized by successive extractions with an 
equal volume of phenol:chloroform:isoamyl alcohol (25:24:1) and 
chlorofoim:isoamyl alcohol (24:1). Nucleic acids and a copious white precipitate of 
glycogen from the liver were recovered by precipitation with 2 volumes of ethanol 
at - 20 °C. After washing the pellets with 70% ethanol, they were redissolved on 
0.5 ml SET buffer containing 200 \ig hog pancreas a-amylase/ml and incubated for 
1 hr at 37 °C. Samples containing dissolved glycogen initially had a slightly 
opalescent or milky appearance but were rendered clear by hydrolysis of the 
glycogen with a-amylase. Nucleic acids were precipitated with ethanol, then 
redissolved in 0.7 ml SET buffer containing 0.1 mg/ml heat-treated pancreatic 
RNase A. After a 1 hr incubation at 37 "C, 70 ng proteinase K in 10 pi water was 
added to the tubes, which were incubated another hour. Samples were diproteinized 
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with phenol and phenol:chlorofonn:isoamyl alcohol. The DNA was recovered and 
purified by two consecutive precipitations with ethanol. Purified DNA was 
redissolved in Tris (10 mM) EDTA (0.1 mM) buffer, and quantitated by its UV 
absorption at 260 nm, using the relationship of 1 absorbance unit = SO |Xg/ml. The 
liver sample of the carp contained a total of 200 |ig of DNA. 
The women's placental DNA samples and (+)-anti-BPDE-DNA sample with 
low modification level of 8:10^ (adducts:base pairs) were provided by Dr. A, 
Jeffrey (Institute for Cancer Research, Columbia University, New York, NY). 
Twenty placental samples were collected from term, uncomplicated pregnant 
women who either were or were not smoking. The placental DNA was extracted in 
the similar way as Everson et al. (58, 65). (+)-anti-BPDE-DNA sample was 
obtained from lOTl/2 cell cultures treated with [^H]-benzo-[a]pyrene (0.004 
mg/mL) for 24 hrs. [^H]-benzo[a]pyrene was obtained from Amersham Searle, 
Arlington Heights, IL. Other chemicals were commercially available from standard 
sources. The cells were grown as previously described in Ref. 94. After treatment 
with the [^H]-benzo[a]pyrene, the cells were washed with PBS and scraped from 
the plates. The DNA was extracted using methods similar to those described in 
Ref. 94. The nuclei, isolated disruption of the cytoplasmic membrane by Triton 
X-100, were solubilized with a 1% SDS solution at pH 6.9, containing 15 mM 
NaCl and 1.5 mM citrate. This solution was then extracted several times with 
water-saturated phenol before the DNA was precipitated from the aqueous phase 
with two volumes of ethanol. The DNA was redissolved and treated with RNase 
before re-extraction with phenol and two ethanol precipitations. The modification 
levels of these adducts were also determined by the Randerath procedure. 
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C. Instrumentation 
The instrumentation used for low temperature fluorescence experiments can be 
divided into four major components: a spectrally narrow excitation source, a low 
temperature dewar as a sample chamber, a monochromator for dispersing the 
fluorescence, and a detection system. Figure 4 presents a block diagram of the 
FLNS apparatus that uses a Tracor-Northem TN-6134 photodiode array as the 
detector. Since this set-up has been described in detail recently (87), only a brief 
discussion will be given here. 
The excitation source used in this laboratory is a dye laser (Lambda Physik 
FL-2002) pumped by an XeCI (Ne buffer gas) excimer laser (Lambda Physik EMG 
102 MSC). It can provide high energy (165 mJ/pulse) pulses at a repetition rate of 
30 Hz at 308 nm. The firing of the laser is triggered by a synchronized electronic 
output pulse. Since the trigger pulse slowly drifts with time and thyratron 
temperature, a Lambda Physik EMG-97 Zero Drift Controller (ZDC) is used to 
correct for this long-term temporal drift, and provides a new "truly" synchronized 
output trigger pulse which occurs ~ 10 (isec before the laser pulse. The output 
from the excimer laser is used to pump the dye laser system. The dye laser uses a 
grazing incidence grating in a Littrow geometry for wavelength selection. The 
excitation wavelength from 340 to 410 nm was selected for the present work by use 
of various dyes, p-Terphenyl, DMQ, PBD, BBQ, and PBBO. The conversion 
efficiency of the dye lasers is typically from ~ 4% to 8%, and thus, the excitation 
powers range from 2 to 13 mJ/pulse. The output beam of the dye laser has a 
spectral linewidth of 0.22 cm"^ and a temporal width of ~ 10 ns. It has a 
symmetrical trapezoid shape with approximate dimension of 2 mm by 3 mm. This 
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output is then shaped using a quaitz biconvex lens and a quaitz plano-convex 
cylindrical lens combination into 10 mm x 2 mm beam to insure complete 
irradiation of the sample. The excitation power density at the sample can be 
adjusted from 5 to 500 mW/cm^. Fluorescence is collected at right angles to the 
excitation and is focused into a 1-meter McPherson 2061 scanning monochromator 
(F 7.0) using two 50-mm diameter quartz lenses. The first lens is used to collect 
and collimate the fluorescence, and the second is used to match the f-number of the 
monochromator. The monochromator is equ^ped with a 2400 grooves/mm grating 
and is able to provide a reciprocal linear dispersion of 0.416 nm/rnm. The 
resolving power of the monochromator (A/AA,) can be optimized to above 60000 at 
5 |im slit width. However, considering that the slit width is often set at 300 |Xm 
when the concentration of the samples is very low, the monochromator usually has 
a bandpass of 0.12 nm (~ 10 cm'^). Therefore, the widths of the zero-phonon lines 
in the FLN spectra are monochromator-limited. 
Two kinds of fluorescence detector systems were used for the present work. 
The first utilized a photodiode array (PDA), and the second utilized a 
photomultiplier tube (PMT). There were two different photodiode array systems 
used in this study. Figure 4 presents the arrangement for Tracor-Northem TN-6134 
blue-enhanced gateable photodiode array. The diode array consists of 1024 diodes 
(25 |i X 2.5 mm) with 700 diodes intensified. These intensified photodiodes cover 
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Figure 4. Block diagram of the FLNS instrumentation using Tracor-Northem TN-
6134 photodiode array as the detector excimer laser (Exc. L), dye laser 
(Dye L), cryostat (C), sample (S), photodiode array (PDA), 
monochromator (M), optical multichannel analyzer (OMA), and printer 
(P). See text for discussion 
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the spectral window of ~ 6 nm for the monochromator used. The resolution of the 
diode array is 4 channels FWHM and was calibrated as described by Zamzow (88). 
The uncertainty for the measured vibrational frequencies of the FLN peaks can be 
reduced to ± 3 cm'\ The PDA can be gated to discriminate between scattered laser 
light and low levels of fluorescence. Gated detection of the fluorescence is 
accomplished by use of the synchronous output pulse of ZDC to trigger a pulse 
generator (Berkeley Nucleonic Corporation (model 8010)) acting as a delay 
generator (DG). The delay generator can set delay from 0 to 1 seconds between 
the laser pulse and the temporal window of the detector. The gate width of the 
temporal window can be set from 5 to 120 nsec by use of an Avtech high voltage 
switch (model AVL-TN-1). All data acquisition and processing, including 
automatic background subtraction and magnetic disk data storage, were performed 
by use of an optical multichannel analyzer (OMA) manufactured by Tracor-
Northem Corporation (model TN-6500). 
The PMT system is mainly utilized to perform the broad fluorescence 
experiments at 77 K and fluorescence narrowing excitation experiments {cf. Figure 
5). The Amperex XP-2232 photomultiplier tube is specially wired for fast signal 
response (95). The fluorescence signal from the PMT is sent to a SRS Model 
SR250 boxcar averager (BXC. I). The SR250 boxcar consists of a gate generator, a 
fast gated integrator, and exponential averaging circuitry. The synchronous output 
pulse of ZDC triggers the gate generator, which provides both an adjustable delay 
from a few nanoseconds to 0.1 seconds and a continuously adjustable gate from 2 
nanoseconds to IS milliseconds. The fast gated integrator integrates the 
Exc. L -x> 
s fPÏÏI 
Z D C  
sync 
BXC. II A/DM. 
Ana. P 
BXC.I 
W 
Figure 5. Block diagram of the fluorescence instnimentation using Amperex XP-2232 photomultiplier tube 
as the detector excimer laser (Exc. L), dye laser (Dye L), cryostat ((]), sample (S), 
photomultiplier tube (PMT). monochromator (M), SRS Model SR250 boxcar averager (BXC I or 
n), SRS Model SR23S analog processor (Ana. P), SRS model SR24S computer interfacing 
module (A/D M.), and computer (Comp). See text for discussion 
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input signal acquired during the gate. The output from the integrator, is then 
normalized by the gate width to provide a voltage which is proportional to the 
average of the input signal during the sampling gate. The averager circuitiy makes 
a moving exponential average over 1 to 10,000 samples available to pull small 
signals from noisy backgrounds. The laser beam intensity is monitored by a 
reference photodiode, and the signal is input to the second channel of the boxcar 
averager. The signals from the PMT and reference photodiode are input to a SRS 
Model SR235 analog processor, where they are ratioed in order to compensate for 
pulse-to-pulse jitter from the laser. The analog signal from the analog processor is 
then converted into a digital signal through the SRS model SR245 computer 
interfacing module, and the data acquisition is accomplished by a accompanied 
computer program SR267. All spectra obtained from PDA and PMT systems can 
be transformed into files of "Spectra Calc" and "MASS 11-DRAW," commercial 
computer graphic programs which greatly facilitate spectral processing. 
The second PDA detector system used a PI Inc. Spectrometric Multichannel 
Analyzer system (OSMA). The Model IRY-1024 detector for this study consisted 
of 1024 photodiodes optically interfaced to a microchannel plate (MCP) image 
intensifier through an optical-fiber coupler. The combined high gain (more than 
10® electron multiplier) of the MCP image intensifier and the low readout noise of 
the diode array resulted in a very sensitive detector capable of responding to a 
single photoelectron. Moreover, the detector is able to detect, measure, and 
manipulate spectra at high acquisition rates (33 msec) with an excellent dynamic 
range, high resolution, and excellent overall accuracy and performance. A block 
diagram of the OSMA system is illustrated in Figure 6. The system comprises the 
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computer console, ST-120 Detector Controller, FG-100 Gate Pulse Generator, and 
an IRY-1024 Detector. The synchronous output pulse from ZDC is used to trigger 
the Model FG-100 Gate Pulse Generator. The FG-100 puiser is primarily designed 
to provide high speed gating with pulse delay control. Low voltage pulse (200 V) 
is used to gate on/off the detector. Combined with Pi's high conductivity 
photocathodes, it is possible to obtain gating times as short as S nsec. The time 
interval between the trigger pulse and the output pulse is continuously adjustable 
from 20 to 1700 nsec. Considering that the synchronous output pulse of ZDC 
precedes laser light pulse, the actual delay time from 0 to 1500 ns can be set by 
FG-100. The detector controller (Model ST-120) provides power, thermostat, and 
timing signals to the detector head, coordinates data gathering with experiments, 
sets exposure time, digitizes and averages data, temporarily stores data and 
transmits it to an IBM/AT computer. A combination of a ST-120 controller with a 
FG-100 puiser provides versatile trigger modes which can meet a variety of 
experimental requirements. The mode illustrated in Figure 6 is used to monitor a 
free-running pulsing laser which operates asynchronously with the ST-120. The 
timing of this mode can be described as following: the ST-120 can be set for a few 
delays. No scan ensures no read during the FG-100 gating period. At the end of 
the exposure time, the spectra are summed and the spectral data are sent to the 
computer. In this mode since the laser is the MASTER and thus directly controls 
the FG-100, the temporal-jitter from the laser pulse can be greatly eliminated. 
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Figure 6. Block diagram of present FLNS instnimentation: excimer laser (Exc. L), 
dye laser (Dye L), cryostat (C), sample (S), photodiode array (PDA), 
monochromator (M), spectrometric optical multichannel analyzer 
(OSMA), gate pulse generator (FG-100), detector controller (ST-120), 
and computer (Comp). See text for discussion 
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IV. RESULTS AND DISCUSSION 
A, Laser Spectroscopic Studies of DNA Adducts Structure Types from 
Enantiomeric Diol Epoxides of Benzo[a]pyrene^ 
A methodology based on 77 K laser-excited fluorescence spectroscopy, 
fluorescence quenching and fluorescence line narrowing is shown to be a highly 
selective and sensitive approach for the study of polycyclic aromatic 
carcinogen-DNA complexes. Three and five different DNA adducts derived from 
(+)-trans-7,8-dihydroxy-anti-9,10-epoxy-7,8,9,10-tetrahydro-benzo[a]pyrene and its 
(-)-enantiomer are identified, respectively. Two different methods are used to 
classify the adducts as type I (interior) or type n (exterior), and both yield 
consistent results. The first high resolution fluorescence excitation spectra are 
reported for DNA adducts. These spectra are suggested to be useful for 
characterizing the strength of the interaction between the fluorescent chromophores 
and the DNA bases. "Die above methodology has the potential for monitoring the • 
fates of different adducts as a function of time in repair-competent cells. 
^ Detailed results and discussion for this topic are described in Paper I which 
is located in Appendix A. 
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B. A Comparative Laser Spectroscopic Study of DNA and Polynucleotide 
Adducts from the (+)-anti-diol Epoxide of Benzo[a]pyrene 
Fluorescence line narrowing spectroscopy in combination with fluorescence 
- quenching and 77 K laser-excited fluorescence spectroscopy is shown to be a 
powerful approach for characterization of chemically and/or structurally different 
adducts of (+)-anti-BPDE formed from DNA and the synthetic polynucleotides. 
Three polynucleotide duplexes ((poly(dG-dC)poly(dG-dC), poly(dG)-poly(dC), 
poly(dA-dT)poly(dA-dT)) and single strand poly(dG) were used in this study, and 
the spectral characteristics and the quenchability of each corresponding adduct were 
elucidated. The alternating poly(dG-dC) poly(dG-dC) yields (+)-! and -2 adducts 
which are most similar to the trans N^-dG adducts of DNA. Fluorescence 
experiments with trans and cis standards of N^-dG from (+)-anti-BPDE and 
guanine monophosphate were the bases for this stereochemical assignment. The 
model (+)-anti-BPDE adducts of the oligonucleotide d(ATATGTATA) were studied 
spectroscopically. The results further confirm our previous conformation 
assignment of (+)-l as a type n adduct and (+)-2 as a quasi-intercalated adduct, and 
indirectly supports (+)-3 as an intercalated adduct. In addition, the FLN spectra of 
(+)-anti-BPDE-DNA reveal a new minor adduct, (+)-4, which is assigned as N^-dA 
on the base of the spectra of standard (+)-anti-BPDE-poly(dA-dT)poly(dA-dT) 
^ Detailed results and discussion for this topic are described in Paper B which 
is located in Appendix B. 
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Finally, the 77 K fluorescence spectroscopy revealed three different species of 
racemic anti-BP tetraol which have been physically mixed with DNA and poly(dG). 
Their spectral characteristics and quenchability are also presented, which will be 
greatly conducive to the spectral analysis of "real adducts". 
C. FLNS Identification of the DNA Adducts from Different BPDE stereoisomers 
in vitro and in vivo 
1. FLNS identification of DNA adducts formed from different BPDE stereoisomers 
in vitro 
Two central dogmas underlie modem research in chemical carcinogenesis. 
The first is Miller's (13) hypothesis that the active forms of most carcinogens are 
electrophilic intermediates formed metabolically. The second is the assumption that 
the initial step in the induction of tumors is the covalent binding of the active 
carcinogen species to a cellular macromolecule, generally presumed to be DNA (1, 
7, 13, 24). Most chemicals require some type of metabolic activation to produce 
the reactive species capable of covalently binding to cellular macromolecules. 
Polycyclic aromatic hydrocarbons (PAH) can be activated by two main pathways: 
monooxygenation to produce bay-region diol-epoxides (21, 22) and one-electron 
oxidation to yield reactive intermediate radical cations (83, 96, 97). 
In the monooxygenation pathway, cytochrome P450 and aryl hydrocarbon 
hydroxylase catalyze conversion of PAHs to more water-soluble oxygenated 
derivatives (13-16). Among these PAH derivatives, bay-region diol epoxides are 
the most reactive and biologically active. BaP has a bay-region structure (cf. 
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Figure 1) and can be metabolized into bay-region diol epoxides, which are believed 
to be the ultimate carcinogenic species (14, 15, 18-20). The metabolism of BaP 
into BPDE through a monooxygenation pathway usually occurs in a three-step 
process. First, BaP loses an electron and is oxidized to the 7,8-oxide. The 7,8-
oxide is then hydrolysed to 7,8-dihydro-7,8-dihydroxy BaP. In the third step, the 
dihydroxy BaP loses the second electron to form 7,8-dihydroxy-9,10-epoxy-
7,8,9,10-tetrahydro-benzo[a]pyrene (BPDE). 
There are four stereoisomers of BPDE, designated as (±)-anti-BPDE and (±)-
syn-BPDE. The structures of these stereoisomers are illustrated in Figure 1. In 
syn-BPDE, the benzylic hydroxyl group and the epoxide oxygen atom are on the 
same side, and in the anti-isomers, they are on the opposite sides. All four 
stereoisomers of BPDE have been tested as carcinogens. (+)-anti-BPDE is the most 
potent carcinogen in mammalian cells, while (-)-anti- and syn-isomers are at best 
only weakly active (36, 98-100). Therefore in carcinogenic research, it is important 
to develop highly selective bioanalytical techniques which have sufficient resolution 
to distinguish these adducts with very similar structures but quite different 
biological activities. The ideal technique should also be very sensitive and 
applicable to small samples of DNA (~ 100 jig) with low adduct levels since 
typical DNA damage levels in in vivo systems are very low (~1 adduct in 10® base 
pairs). 
DNA adducts formed from (+)-anti, (-)-anti, and syn-BPDE in vitro were 
determined by FLNS. The pertinent FLN spectra, obtained with = 369.6 nm 
and T = 4.2 K, are presented in Figure 7. These DNA adducts are readily 
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Figure 7. Comparison of the FLN spectra of three different DNA adducts from 
different BPDE stereoisomers. All spectra obtained in the standard 
gly/HjO glass at T = 4.2 K. = 369.6 nm. 
A: (+)anti-BPDE-DNA; 0.5% bases modified, 
B: (-)anti-BPDE-DNA; 1.5% bases modified, 
C: syn-BPDE-DNA; - 1 adduct in 10^ bases 
The FLN peaks are labeled with their corresponding excited state 
vibrational frequencies (cm*^) 
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distinguished from each other primarily on the basis of differing vibronic intensity 
distributions. The spectrum of (+)-anti-BPDE-DNA (Figure 7A) is characterized by 
its major ZPL with the vibronic frequency of 579 cm'^ and a second ZPL with the 
" vibronic frequency of 757 cm"'. The intensity of the 757 cm"* band varies with the 
adduct level and will be discussed later. The spectrum of (-)-anti-BPDE-DNA 
(Figure 7B) seems more complicated. The 579 cm"' band is still a major band, but 
the 757 cm"' band becomes almost as strong as the band 579 cm"'. Underneath the 
757 cm"' band is an intense broad fluorescence band which contains contributions 
from intercalated adducts and tetrols, vide supra. The most characteristic band in 
the spectrum of the (-) adduct has the vibronic frequency of 828 cm"'. It is a very 
strong band in the spectrum of (-)-anti-BPDE-DNA, but too weak to be noticeable 
in the qjectra of (+)-anti- and syn-BPDE-DNA adducts. With the major 579 cm"' 
band, the strong doublet bands 757 and 828 cm"' in Figure 7B are very 
characteristic and can be used to test for the existence of (-)-anti-BPDE-DNA. The 
spectrum of syn-BPDE-DNA (Figure 7C) is readily distinguished from the spectra 
of (±)-anti-BPDE-DNA on the basis that the strongest vibronic mode in the 
spectrum of the syn-adducts has a vibronic frequency of 616 cm"', rather than 579 
cm"', as in the spectra of the anti-adducts. In addition, the spectram 7C contains 
another strong FLN band with the vibronic frequency of 761 cm"', which is 
superimposed on a strong broad fluorescence feature. The triplet structure in the 
FLN spectrum C, comprised of the 555, 590 and 616 cm"' bands, may be viewed as 
characteristic of the syn-adducts. 
In the study of BaP carcinogenesis, particular significance is placed on 
identifying the existence of (+)-anti-BPDE-DNA, since it is believed to be 
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Figure 8. Laser excited fluorescence spectra of (+)anti-BPDE-DNA, 0.5% bases 
modified. 
A: T = 77 K, = 346 nm, broad fluorescence spectrum, 
B: T = 4.2 K, = 369.6 nm, FLN spectrum 
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Figure 9. Comparison of the FLN spectra of (+)anti-BPDE-DNA at different 
concentrations, T = 4.2 K, = 369.6 nm. 
A: ~ 1 adduct in 5000 bases, 
B: ~ 1 adduct in 8x10^ base's 
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the most potent carcinogen of all possible species. The 77K fluorescence spectrum 
of (+)anti-BPDE-DNA is the simplest spectrum, and exhibits a major band (denoted 
as (+)1) located at 378.0 nm (c/. Figure 8A). Since it is subject to significant 
quenching by ACR and has a great R-value, this band has been identified as being 
from covalently bound adduct which lies toward the exterior of the DNA double 
helix {cf. Appendix A: Paper I). Based upon the fact that 90% of (+)-anti-BPDE 
binds to of deoxyguanine (38), the 378 nm band contains significant 
contribution from N^-dG-BPDE adduct. Since the laser with = 369.6 nm 
selectively excites the vibronic bands of Sj of the BPDE adducts, the pertinent FLN 
spectra will exhibit ZPL peaks derived from fluorescence origin. To (+)-anti-
BPDE-DNA, the laser frequency is located about 600 cm*^ higher in energy than 
the origin band for (+)1 or N^-dG-BPDE adduct. Therefore, the vibronic mode 
from the origin band of the FLN spectrum is characterized with the vibronic 
frequencies in the vicinity of 600 cm'^ According to this analysis, the major band 
579 cm"' in the spectrum SB (or 7A) is primarily originated from origin band of 
(+)1 and contains significant contribution from N^- dG-B.PDE adduct, too. 
Figure 9 shows the FLN spectra of (+)-anti-BPDE-DNA with high (1:5000) 
and low (1:8x10^) BPDE adduct modifications. The relative intensity of the broad 
underlying fluorescence in spectrum 9B is much greater, which shows that the 
relative level of the intercalated adducts and possible tetrads produced by 
degradation in the low modification sample is higher. Another difference between 
the two spectra is the relative intensity of the 757 cm"' ZPL. It is a moderately 
strong in the spectrum of the low modification sample, but weak in the spectrum of 
the high modification sample. On the basis of the 757 cm"' band's location and its 
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quenching behavior, we conclude that it contains a significant contribution from 
(+)2 (c/. Appendix A, Paper I). The relative increase in intensity of the 757 cm'^ 
band with addition of the quencher indicates an increase in the relative 
" concentration of the quasi-intercalated (+)2 adduct in the low modification sample. 
From this study, an argument can be made that the relative amount of exterior and 
interior (quasi-intercalated or intercalated) depends upon the total modification 
level. Therefore, it is important for in vitro studies that a low modification level, 
comparable to those of in vivo samples, be employed. 
2. FLNS identification of the liver DNA adducts of English sole exposed to 
BaP in vivo 
Spontaneous tumors have occurred in a wide variety of fish species from both 
freshwater and marine environments (101). Although some studies have suggested 
that increased frequencies of some kinds of fish neoplasms may be the result of 
exposure to carcinogenic pollutants occurring in aquatic environments (102, 103), 
there has been no direct proof of this hypothesis until recently (42, 44, 45). It has 
also been suggested by Dawe et al. (46) that bottom-feeding fish species exhibit 
increased frequencies of neoplasms and thus may serve as early warning indicators 
of carcinogenic hazards to man. Our research focused on the study of the 
metabolic activation of PAH in the liver tissues of English sole, because this fish 
species exhibits a high prevalence of liver neoplasms in several PAH-contaminated 
areas (44, 45). The significance of this study is further emphasized by the finding 
that long-term exposure of English sole to BaP results in a spectrum of toxicopathic 
lesions similar to those observed in fish captured from contaminated areas (54). 
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Figure 10. Comparison of the FLN spectra of the liver DNA samples of English 
sole exposed to BaP in vivo with standard BPDE-DNA adducts formed 
in vitro, T = 4.2 K, Xg, = 369.6 nm. 
A; The liver DNA of English sole exposed to 100 mg BaP/kg of 
fish, 
B: Syn-BPDE-DNA, ~ 1 adduct in 10^ bases, 
C: The liver DNA of English sole exposed to 50 mg BaP/kg of fish, 
D: (+)anti-BPDE-DNA, - 1 adduct in 8x10^ bases 
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Enzymatic hydrolysis and analysis by reversed-phase HPLC of hepatic DNA 
isolated from English sole exposed to radiolabeled BaP, however, did not show the 
presence of detectable levels of BPDE-DNA adducts (55). A recent study (56) 
using English sole hepatocytes exposed to ^H-BP showed no detectable BPDE-dG 
adducts. The adduct level in this in vivo fish samples apparently very low, and a 
highly sensitive bioanalytical technique is imperative in this study. 
The first in vivo sample tested was liver DNA of English sole exposed to a 
high dose of BaP (100 mg/kg. b.w.). The pertinent FLN spectrum obtained with 
= 369.6 run, is shown in Figure IDA. Even though the adduct level is very low 
(~ 1 adduct in 10^ bases as determined by ^^P-postlabeling (55)), the FLN spectrum 
exhibits an acceptable signal to noise ratio. Spectral analysis of the fish DNA 
spectrum reveals a characteristic triplet structure with the major ZPL band having 
the vibronic frequency of 616 cm"^ Another strong ZPL has a vibronic frequency 
of 761 cm'\ and is superimposed on a broad fluorescence feature. For comparison, 
the standard spectra of syh-BPDE-DNA and (+)-anti-BPDE-DNA are also presented 
in Figures lOB and lOD, respectively, which were obtained during the same run 
with the fish DNA spectrum. Based upon the analysis of the vibronic frequencies 
and the intensity distribution of the vibronic modes, the major adduct formed in the 
fish liver DNA can be identified as syn-BPDE-DNA. 
Although anti- and syn-BPDE are both strongly mutagenic in bacterial and 
mammalian cells, anti-BPDE shows generally greater activity than syn-BPDE in 
most tests (15, 26). Therefore, in this study, particular emphasis was placed on 
determining whether or not (+)-anti-BPDE-DNA adduct is formed in English sole. 
In fact, even for highly PAH-contaminated areas like the Buffalo River and Detroit 
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River, the levels of individual PAH detected in the water ranged from 0.1 to 38.8 
fig PAH/g water (42, 43). Therefore, fish exposed to lower doses of BaP are 
expected to provide a more realistic profile of adducts formed in nature. The 
" second sample tested was the liver DNA of English sole exposed to a lower dose of 
BaP (50 mg/kg b.w.), the resulting FLN spectrum is shown in Figure IOC. 
Comparison of this spectrum with spectrum A reveals that the two are very 
different, i.e. the FLN spectrum depends on dosage level. The most intense ZPL in 
spectrum IOC is not 616 cm"\ but rather 579 cm'^. It is characteristic of anti-
BPDE-DNA. Since the strong doublet bands 757 and 828 cm"^ are not observed, 
the major DNA adduct in the liver of English sole exposed to the lower dose of 
BaP is identified as (+)-anti-BPDE-DNA. 
Further analysis reveals that the spectrum IOC is not quite identical to the 
corresponding spectrum of (+)-anti-BPDE-DNA, cf. spectrum lOD. The major 579 
cm'^ band in IOC is broader and has a small shoulder with the vibronic frequency 
of ~ 590 cm"'. Another band to the right of the 579 cm"' band has a vibronic 
frequency of ~ 616 cm"', and a third band is also noticeable to the left with the 
frequency of ~ 555 cm"'. Although the signal to noise ratio is rather poor, a triplet 
stmcture in spectrum IOC is discernible with the 616 cm"' band being the strongest. 
Consequently, even though the major DNA adduct of the fish exposed to the lower 
dose of BaP is derived from (+)-anti-BPDE-DNA, a weak contribution from syn-
BPDE-DNA cannot be excluded. Moreover, at ~ 381 nm there exists a broad 
fluorescence band, which adds further evidence for this argument. Similar results 
were also obtained by Varanasi et al. (53), by the use of the ^^P-postlabeling 
method. They showed that when English sole were exposed to 100 mg BaP/kg 
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b.w., 70 percent of liver DNA adducts formed were syn-BPDE-DNA, with the rest 
being anti-BPDE-DNA; however, for lower doses of BaP (2-15 mg/kg b.w.), only 
anti-BPDE-DNA adducts were, detected in the fish liver DNA. They did not 
" determine if the anti-BPDE-DNA arose from (+)-anti or (-)-anti-BPDE. 
It has been found that in the cytochrome P450 enzyme family, different forms 
of P450 preferably catalyze conversion of BaP to either syn- or anti-BPDE or both 
(104). Since each animal cell or tissue contains different enzyme systems, different 
proportions of anti- and syn-BPDE-DNA can form in different animal cells or 
tissues. Large quantities of syn-BPDE-DNA adducts were detected in hamster 
epidermal cells, while in rabbit dermal fibroblast (+)-anti-BPDE-dG accounted for 
~91% of the adducts (105). In the rat dermal fibroblast syn-BPDE-dG represented 
more than 40% of the adducts (105), while in the rabbit cell it only accounted for ~ 
5% (105). However, our experiment reveals another phenomenon—that different 
adduct developed in vivo is dependent upon the BaP exposure level. This result 
poses an interesting problem for the study of the metabolic activation of BaP. 
Kano's experiment (106) may give some clue to explain this phenomenon. 
Kano et al. (106) found that the interaction of BaP with a protein receptor molecule 
could induce the production of cytochrome P450c, which was 25-180 times as 
active as other forms of cytochrome P450. It is possible that the high dose of BaP 
promotes the production of cytochrome P450c, which then catalyzes the metabolic 
reaction to yield syn-BPDE. 
The results from this study provide direct evidence for the formation of the 
suspected ultimate carcinogen through the monooxygenation pathway, BPDE, in 
liver of English sole exposed to BaP in vivo, and thus further support the 
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hypothesis that exposure to PAH is an important factor in the etiology of hepatic 
neoplasms in English sole from contaminated sites. 
3. Conclusions 
Despite their very similar stmctures, (+)-anti- , (-)-anti-, and syn-BPDE have 
quite different biological activities. This study shows that FLNS has sufficient 
resolution to distinguish the DNA adducts formed from these different BPDE 
stereoisomers in vitro. The vibronic modes from the fluorescence origins with the 
frequencies from 550 to 850 cm"^ provide the best "finger print" for identification 
of these different BPDE-DNA adducts. The spectra obtained can be used as 
standards for the study of other in vitro and in vivo systems. FLNS is also 
successfully applied to identify DNA adducts in the liver of English sole exposed to 
different doses of BaP in vivo. The fish species selected exhibits a high prevalence 
of liver neoplasms in several PAH-contaminated areas. When the fish is exposed to 
the lower dose of BaP (50 mg BP/kg b.w.), the major DNA adduct developed in the 
fish liver is identified as (+)-anti-BPDE-DNA, one of the most potent carcinogen 
species. However, at a high exposure (100 mg/kg b.w.), the major adduct 
developed in the fish liver DNA is syn-BPDE-DNA. The observation that the 
major adducts formed varied with exposure to different doses of BaP may pose an 
interesting problem in the study of metabolic activation. The results from this 
study provide the direct evidence for the formation of the suspected ultimate 
carcinogen through the monooxygenation pathway, BPDE, in liver of English sole 
exposed to BaP in vivo, and thus further support the hypothesis that exposure to 
PAH is an important factor in the etiology of hepatic neoplasms in English sole 
from contaminated sites. 
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D, Laser-Excited Ruorescence Spectroscopy Study of DNA Damage to 
Women's Placenta and Fish Exposed to Widespread Environmental 
Pollutants 
1. Characterization of DNA-adducts in women's placenta samples 
In recent years, research in chemical carcinogenesis has been directed to 
human systems. The ^^P-postlabeling assay and the immunologic technique ELISA 
(using antibodies to chemically modified DNA in enzyme-linked immunosorbent 
assay) have been successfully used to detect carcinogen adducts from women's 
placental DNA samples (58, 64, 65). A total of seven different adducts were 
detected in the 53 subjects, and three of these adducts were found almost 
exclusively in smokers. Everson and co-workers (65) observed by ELISA that the 
antibodies modified by anti-BPDE have a positive response to the placenta DNA 
adducts. Since other adducts formed from anti-benz[a]anthracene diol epoxide and 
anti-chrysene diol epoxide also reacted with the developed antibodies (66, 67), they 
could not verify that the placenta DNA contained anti-BPDE-DNA adducts. The 
problem is that neither the chemical origin of the adducts nor their precise 
structures have been determined to date. The exposure or susceptibility factors that 
are most closely associated with biochemical or molecular damage to human tissues 
are still a mystery (65). Furthermore, identification of the DNA adducts formed 
from the diAerent stereoisomers of a chemical carcinogen in human tissues is also 
of particular significance, since different stereoisomers of a chemical carcinogen 
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can have quite different mutagenicities and tumorigenicities (17, 33, 98, 107-109). 
Hence, further studies of carcinogenesis in humans require highly selective and 
sensitive assay techniques which not only can detect very low adduct levels (pmol 
to fmol), but also characterize the chemical origins and specific stereochemistry of 
the adducts as well. 
Placental DNA samples were dissolved in the standard glycerol/ethanol/water 
glass, and all the samples were degassed to eliminate the oxidation and quenching 
effect from oxygen. FLN spectra of the placental DNA samples were obtained for 
all the standard vibronic excitation wavelengths used to characterize BPDE-DNA 
adducts. The first FLN spectrum from human placental DNA samples was obtained 
at excitation = 369.6 nm, shown in Figure 11 A. Spectram llA is characterized 
by three major peaks with vibronic frequencies of 535, 558, and 588 cm"^. FLNS 
first exhibits a high sensitivity in detection of the low concentration of the DNA 
adducts from the human tissues. Seven out of twenty placental samples analyzed 
exhibit FLN spectra similar to that in Figure 11 A, four of these seven DNA 
samples are from smokers, and three are from non-smokers. The spectra of (+)-
anti- and syn-BPDE-DNA adducts are presented in Figures IIB and IIC for 
comparison. Careful analysis of the placenta DNA spectrum finds that its major 
band 588 cm'^ has a small peak on the left side, with vibrational frequency of 579 
cm"'. This is a typical vibronic mode for anti-BPDE-DNA adducts. Another small 
band in the placenta DNA spectmm can be noticed with the vibrational frequency 
of 757 cm"*, which is also a typical peak for anti-BPDE-DNA adducts. Since there 
is no 828 cm"' band with the proper intensity observed, the adduct can be identified 
as (+)-anti-BPDE-DNA. Other vibronic modes of (+)-anti-BPDE-DNA can be observed 
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Figure 11. Comparison of the FLN spectra of the placental DNA adducts (A) with 
standard (+)- and syn-BPDE-DNA (B, C). All spectra obtained in the 
standard gly/H^O glass at T = 4.2 K. = 369.6 nm. 
A: Placental DNA adducts; the samples were degased, 
B: (+)anti-BPDE-DNA; ~ 1 adduct in 8x10^ bases, 
C: Syn-BPDE-DNA; ~ 1 adduct in 10^ bases 
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Figure 12. Comparison of the FLN spectra of the placental DNA adducts (A) with 
standard (+)- and syn-BPDE-DNA (B, C). All spectra obtained in the 
standard gly/H^O glass at T = 4.2 K. = 356.9 nm. 
A: Placental DNA adducts; the samples were degased, 
B: (+)anti-BPDE-DNA; - 1 adduct in 8x10^ bases, 
C: Syn-BPDE-DNA; ~ 1 adduct in 10^ bases 
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in the FLN q)ectra of the placenta samples obtained with different excitation 
wavelengths. Figure 12 shows the FLN spectra of the placenta sample and the 
standard BPDE-DNA samples obtained for = 356.9 nm. The FLN spectra of 
" BPDE adducts usually display strong vibronic modes under such an excitation, 
since their absorption extinction coefficients are large there. The typical bands 
(1559 cm"^ and 1615 cm'^) of (+)-anti-BPDE-DNA can be readily recognized from 
the spectrum 12A. Analysis of the relative intensities and vibronic frequencies of 
the spectral bands of syn-BPDE-DNA shows that the placenta samples do not 
contain any notable amount of syn-BPDE-DNA adducts. Since the major vibronic 
modes of the placenta DNA adducts and (+)-anti-BPDE-DNA have very similar 
vibrational frequencies, they may contain the same kind of fluorescence 
chromophore. In this study, FLNS also exhibits high selectivity, since it directly 
identifies (+)-anti-BPDE-DNA adducts in the human placenta samples. In addition, 
FLNS has sufficient resolution to distinguish these stmcturally closely-related DNA 
adducts. Careful analysis of spectrum 12A can find a small band with the vibronic 
frequency of 1443 cm"^ Since a typical vibronic mode of free BP tetraols has the 
same frequency, the sample may contain small amount of free BP tetraols. This 
assumption has been confirmed by our broad fluorescence experiments and will be 
discussed later. 
Fluorescence spectra were also acquired at 77K to characterize the fluorescent 
chromophores of the placental DNA adducts. Figure 13A displays the fluorescence 
spectrum of the placental sample obtained with = 346.0 nm. Since the 
excitation selected lies close to the absorption maximum of the covalently-bound 
BPDE adducts and free BP tetraols, the laser selectively excites these 
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JFigure 13. Laser-excited fluorescence spectra. Placental DNA adducts (A), BP 
tetrads (B) and (+)anti-BPDE-DNA (C). Gate delay (GD) = 30 nsec, T 
= 77 K, and = 346 nm 
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Figure 14. Laser-excited fluorescence spectra. Placental DNA adducts (A), (BP 
tetrad + DNA) mixture (B) and (+)anti-BPDE-DNA (C). Gate delay 
(GD) = 30 nsec, T = 77 K, and = 355 nm 
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chromophores. The broad, irregular shape of the fluorescence origin band implies 
that the placental DNA contains more than one kind of adduct. The fluorescence 
origin of the placenta DNA adducts is located at ~ 377.5 nm, and the spectral shape 
is similar to those of BP tetraols and (+)-anti-BPDE-DNA (shown in Figures 13B 
and 13C). These spectral characteristics suggest that the major adduct of placental 
DNA contain a pyrene chromophore which is derived from the metabolism of BaP 
through the monooxygenation pathway. The R-value calculated for this adduct is 
-1.6, which shows that the major placental DNA adduct arises from a covalently-
bound adduct. This argument is consistent with the results of HPLC/SFS and 
GC/MS, in which BPDE adduct has been detected in the placental DNA samples at 
an adduct level amounting to 580 pg (110). Percentage of samples found to have 
the adducts by these different techniques is also very similar. 
Laser excitation at 355.0 nm selectively excites intercalated BPDE adducts. 
The pertinent spectrum of the placental DNA is shown in Figure 14A, and the 
spectra of a (BPT + DNA) mixture and (+)-anti-BPDE-DNA are shown in Figure 
14B and 14C, respectively. The spectrum of (BPT + DNA) mixture displays two 
small peaks appearing at 376.1 and 376.8 nm, respectively, which have recently 
been proved to arise from free trans- and cis- BP tetraols (111). The broad peak 
(at -381-nm) of the (BPT + DNA) mixture arises from "quasi-intercalated" tetraols 
and which are subject to severe quenching by acrylamide. The R-value calculated 
from this band is 1.36. One small peak of the placental spectrum appears at 376.8-
nm. The placenta DNA apparently contains a small amount of free BP tetraols 
which is consisted with the result obtained from the FLN experiment. The major 
origin band of the placenta DNA spectmm is located at ~380.6 nm, which is very 
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close to that of the intercalated adducts (+)3. The R-value calculated iFor the (+)3 
adduct is ~ LIS, whereas for the placenta adduct it is ~ 1.25. Since the 
fluorescence origin band of the placenta DNA spectrum is broader than that of (+)3 
and its R-value is higher, the placenta DNA also contains a certain amount of 
intercalated BP tetraols and possible BPT photoproducts {cf. Appendix B). This 
argument can be further confirmed by performing fluorescence quenching 
experiment, for example, using aciylamide. Besides, the existence of a narrowing 
band 757 cm"^ in the FLN spectrum 11A of the placental sample provides 
additional evidence that placenta DNA contains a certain amount of (+)2 adducts. 
The broad fluorescence spectrum 14A of the placenta DNA contains a small 
peak at -372.2 nm. Since neither BaP nor BPDE metabolites were found to have a 
fluorescence origin band in this region, different type of adduct is present in the 
placenta DNA sample. For ease of discussion, this adduct will be designated as 
adduct A. The FLN spectra obtained for adduct A are presented in Figure 15. The 
vibronic frequencies of adduct A do not correlate with those of the BPDE adduct, 
which also shows that they do not arise from the same fluorescence chromophore. 
In addition, even though the broad fluorescence origin band of adduct A is a small 
peak in spectrum 14A, its corresponding ZPL bands are much stronger than those 
of the BPDE-DNA adducts. This means that the adduct A has either a small 
electron-phonon coupling efficiency or a great molar absorption extinction 
coefficient in the excitation region. Adduct A may arise from metabolites of BF 
and DBA. This will be discussed in detail later. 
As a result, using laser-excited fluorescence spectroscopy, four kinds of BaP 
metabolites can be detected in the women's placental DNA samples, and three of 
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these can be characterized. They are (1) (+)-anti-BPDE-DNA adducts, (2) BP 
tetraols, and (3) intercalated BPDE adducts. The major adduct can be identified as 
a covalently-bound adduct having a pyrene chromophore, but it is neither anti- nor 
syn-BPDE-DNA formed in vitro. From the above analysis, we may conclude that 
the metabolic activation of BaP in human tissue (placenta) occurs primarily through 
the monooxygenation pathway. 
2. Carcinogenesis study in fish exposed to several widespread 
environmental carcinogens in vivo 
Searching for the chemical origins of the placenta DNA adducts leads to the 
fish DNA sample (English sole). The characterization of the fish DNA adducts 
may reveal the initial metabolic processes of the chemical carcinogens, since fish 
may be relatively inefficient at repairing DNA adducts (47, 48). English sole were 
exposed to benzo[a]pyrene, benzo[b]fluoranthene (BF), and dibenz[a4i]anthracene 
(DBA). BF is a chemical carcinogen and a widespread environmental pollutant, 
which has been detected in gasoline engine exhaust, urban air, cigarette smoke 
condensate, coal tar, soil, drinking water, and various foods (112). The levels of 
BF in the environment sometimes exceed those of BaP (112). Dibenz[a,h] 
anthracene is one of the major PAHs present in cigarette smoke and is also a 
significant environmental pollutant (113). DBA is a potent chemical carcinogen 
which was found able to induce a variety of neoplasms. Therefore, selection of 
these three widespread environmental carcinogens has a general significance in the 
carcinogenesis research of humans and animals exposed to the contaminants. 
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Figure 15. The FLN spectra of the placental DNA adducts under excitation of 
= 364.0 nm (A), and = 357.4 nm (B) 
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Figure 16. The FLN spectra of the fish DNA adducts with two different excitation 
wavelengths at T = 4.2 K. 
English sole exposed to BaP, BF, and DBA; 
A: = 369.6 nm, 
B: = 356.9 nm, 
Caip from the Buffalo River-
C: = 369.6 nm, 
D: = 356.9 nm 
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Figure 17. 77 K laser-excited fluorescence spectra at = 355 nm. Placental 
DNA adducts (A), the DNA adducts of the English sole exposed to 
BaP, BF, and DBA in vivo (B), and the DNA adducts of the carp from 
Buffalo River (C). GD = 30 nsec 
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The FLN spectra of English sole obtained using two different excitation 
wavelengths are shown in Figures 16A and 16B. The ZPL characteristic of the (+)-
anti-BPDE-DNA can be readily identified in the FLN spectra obtained for the 
English sole DNA sample with the vibrational frequencies of 579, 757, 1559, and 
1615 cm"\ but none is a major band. Therefore, (+)-anti-BPDE-DNA constitutes 
only a minor portion of the adducts present in the English sole sample. 
Surprisingly, the FLN spectra of the English sole DNA sample are very similar to 
those of the placenta DNA. The adducts in the fish DNA have the same chemical 
structures and conformations as those found in the human placenta DNA. This 
indicates that the carcinogens experience the same metabolic pathways in fish as in 
humans. The major adduct in fish is neither anti- nor syn-BPDE-DNA formed in 
vitro, but can be identified as containing a pyrene chromophore, as is the case for 
the placental DNA adduct. The major adduct which forms in English sole exposed 
to a mixture of carcinogens was found by FLNS to be different from that when the 
fish is exposed to BaP only. The results of this study show that co-existing 
substance effects play a very important role in metabolic activations of BaP in 
human and animal systems. 
Figure 17B presents one of the 77K fluorescence spectra of the English sole 
DNA sample obtained for = 355.0 nm. The fish DNA spectrum is very similar 
to the corresponding placental DNA spectmm (Figure 17A). The broad peak at 
-380.5 nm shows that the fish DNA contains a certain amount of intercalated 
BPDE adducts, tetraols, and/or possible photoproducts. A small peak from free BP 
tetraols is located at ~ 376.8 nm. Note that the English sole DNA spectrum also 
contains a small peak at ~ 372.2 nm, so does the carp spectrum. The pertinent 
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FLN spectra of the English sole DNA sample are presented in Figure 18, which 
shows that the major vibronic modes have the same vibrational frequencies 
observed in the placenta DNA spectra (Figure 15), with a similar intensity 
distribution. The adduct A can be identified in the fish sample. Based on the 
knowledge of the chemical carcinogens which the fish were exposed to, the adduct 
A is presumed to arise from metabolites of either DBA or BF. Further experiments 
involving the analysis of DNA samples exposed to BF and DBA in vitro or in vivo 
are necessary to characterize the chemical structure of adduct A. 
This study has shown that fish exposed to three different chemical carcinogens 
developed the same DNA adducts as those present in human placenta DNA, and 
thus we propose that the metabolic activations of BaP with the co-existing 
carcinogens in the fish are the same as in the human placenta. The placenta DNA 
adducts identified by our fluorescence experiments are originated from three 
widespread environmental pollutants BaP, BF, and DBA. The results of this study 
may support the hypothesis that bottom-feeding fish species exhibit increased 
frequencies of neoplasms, and thus, may serve as early warning indicators of 
carcinogenic hazards to man. Finally, this study points out the significance of 
using a mixture of widespread environmental carcinogens in carcinogenesis 
research. 
3. Characterization of the DNA adducts of the fish from contaminated areas 
Several fish species from different contaminated areas were collected, and the 
fish liver DNA was extracted and subsequently analyzed by FLNS. Figures 16C 
and 16D show two of the FLN spectra of the DNA sample of carp captured from 
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Figure 18. The FLN spectra of the fish DNA adducts with two different excitation 
wavelengths at T = 4.2 K. 
English sole exposed to BaP, BF, and DBA in vivo; 
A: = 364.0 nm, 
B: = 357.4 nm, 
Caip from the Buffalo River; 
C: = 364.0 nm, 
D: = 357.4 nm 
Ë 
D 
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the Buffalo River. The spectra of carp DNA are very similar to those of placental 
DNA by comparison of Figure 16C and 16D with Figure 11A and 12A, which 
show that the major DNA adducts in carp DNA sample are the same as those found 
- in the placental DNA and the English sole DNA samples. Since the carp spectra 
do not show any noticeable ZPL with vibrational frequencies of 579, 757, and 1615 
cm"\ the carp DNA sample contains much less (+)-anti-BPDE-DNA adduct. In 
such cases, the amount of free tetraols in the caip DNA sample is also expected to 
decrease. The FLN spectrum 16D of the carp DNA sample shows that the free 
tetraol band 1443 cm"' is very weak. The broad fluorescence spectrum of the caip 
DNA sample was obtained with = 355 nm and is shown in Figure 17C. In this 
spectrum, the free tetraol peak (- 376.8 nm) is apparently much lower than that in 
the corresponding spectra of the placenta DNA and the English sole DNA. The 
pertinent broad fluorescence origin band (~ 380.5 nm) in the spectrum shown in 
Figure 17C is also narrower, which means that carp DNA contains less intercalated 
tetraols. The observation that the carp liver DNA contains much less of potent 
carcinogenic species, (+)-anti-BPDE-DNA, than does English sole is very 
interesting, since English sole exhibit a high prevalence of liver neoplasms, while 
carp rarely develop cancer. 
The origin band of adduct A can also be recognized in the fluorescence 
spectrum of the carp DNA sample shown in Figure 17D, and the pertinent FLN 
spectra of carp DNA are presented in Figures 18C and 18D, which provide 
additional evidence to confimi the presence of adduct A in the caip DNA sample. 
This study, using different fish species, has shown that fish (caip) from a 
contaminated area develop the same major DNA adducts as those found in human 
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tissues. Also, the chemical carcinogens in caip undergo similar metabolic pathway 
as in the human systems. Therefore, the research using fish species is very 
important in the study of environmental exposure of chemical carcinogens to human 
beings. The use of a mixture of several widespread carcinogens may have a 
general significance in carcinogenesis research of in vitro and in vivo systems. 
BaP, BF, and DBA are very important environmental pollutants, worthy to be 
further investigated. 
4. Conclusions 
For the first time, (+)-anti-BPDE-DNA adduct has been directly detected by 
FLNS in the DNA from women's placental samples. Laser-excited fluorescence 
spectroscopy has also identified intercalated BPDE adducts and a small amount of 
free tetraols in the placental DNA. The major adduct of the placental DNA can be 
identified as a covalently bound adduct having a pyrene chromophore, but it is 
neither anti- nor syn-BPDE-DNA formed in vitro. The fact that the major adduct 
in placental DNA has a BPDE chromophore is consistent with the results of 
HPLC/SFS and GC/MS, in which the BPDE adduct has been detected in the 
placental samples at an adduct level amounting to 580 pg. Moreover, laser 
fluorescence spectroscopy has revealed another adduct having fluorescence origin at 
372.2 nm. Further experiments are needed to characterize its specific chemical 
structure. The chemical origins of these adducts can be determined arising from 
three widespread environmental carcinogens: benzo[a]pyrene, benzo[b]fluoranthene, 
and dibenz[a,h]anthracene. The metabolic activations of BaP in the human body 
are mainly through the monooxygenation pathway. 
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This study determines that two different fish species (English sole and caip), 
when exposed to the three carcinogens in vivo and in a contaminated area, 
respectively, develop the same major DNA adducts as those which form in human 
tissue. However, the carp DNA contains much less of the potent carcinogenic 
species, (+)-anti-BPDE-DNA than do English sole DNA. This observation is very 
interesting since English sole exhibited a high prevalence of liver neoplasms (44, 
45, 53), while carp rarely developed cancer (50). When English is sole exposed to 
BaP only, the major adduct which forms is are either syn- or anti-BPDE-DNA 
adducts. However, when the fish is exposed to a mixture of carcinogens (BaP, BF, 
and DBA), the major adduct is neither syn- nor anti-BPDE-DNA formed in vitro. 
Therefore, this study reveals that the formation of the major adduct resulting from 
exposure to BaP in humans and fish is closely associated with the interactions of 
the co-existing carcinogens, which plays a very important role in the metabolism of 
BaP in humans and fish. The results of this study indicate that these carcinogens 
experience the same metabolic pathways in fish and in the human body, which 
provides direct evidence to support the hypothesis that bottom-feeding fish species 
may serve as early warning indicators of carcinogenic hazards to man. Therefore, it 
is very significant to use fish species to study the environmental exposure of 
humans. Finally, this study points out that the use of a mixture of several 
widespread carcinogens may have general significance in carcinogenesis research. 
This study shows that laser-excited fluorescence spectroscopy is a very 
powerful bioanalytical approach to determine macromolecular damage of the tissues 
of humans and animals exposed to widespread environmental pollutants. 
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VI. APPENDIX A. PAPER I. LASER SPECTROSCOPIC STUDIES OF 
DNA ADDUCT STRUCTURE TYPES FROM ENANTIOMERIC DIOL 
EPOXIDES OF BENZO[a]PYRENE 
A. Abstract 
A methodology based on 77 K laser-excited fluorescence spectroscopy, 
fluorescence quenching, and fluorescence line narrowing is shown to be a highly 
selective and sensitive approach for the study of polycyclic aromatic 
carcinogen-DNA complexes. Three and five different DNA adducts derived from 
(+)-trans-7,8-dihydroxy-anti-9,10-epoxy-7,8,9,10-tetrahydro-benzo[a]pyrene and its 
(-)-enantiomer are identified, respectively. Two different methods are used to 
classify the adducts as type I (interior) or type n (exterior), and both yield 
consistent results. The first high resolution fluorescence excitation spectra are 
reported for DNA adducts. These spectra are suggested to be useful for 
characterizing the strength of the interaction between the fluorescent chromophores 
and the DNA bases. The above methodology has the potential for monitoring the 
fates of different adducts as a function of time in repair-competent cells. 
B. Introduction 
The characterization and determination of nucleotide, nucleoside and 
macromolecular DNA adducts are important for understanding the initial phases of 
chemical carcinogenesis. Several biochemical, biophysical, and immuno-chemical 
methods have been developed (1). This work will show that a methodology based 
on 77 K laser-excited fluorescence spectroscopy, fluorescence quenching, and 
fluorescence line narrowing spectroscopy (FLNS) is a powerful approach for the 
study of macromolecular DNA adducts. The reactive metabolites (which form 
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covalent adducts with DNA) selected to test this methodology are (+)-trans-
7,8-dihydroxy-anti-9,10-epoxy-7,8,9,10 tetrahydro-benzo[a]pyrene ((+)-anti-BPDE), 
and its enantiomer (-)-anti-BPDE. While the fomier is highly tumorigenic, the 
. latter is not (2), although both form stable macromolecular DNA adducts (3, 4). 
The differences in their mutagenic and carcinogenic activities (5-8) are likely to be 
due, at least in part, to differences in DNA adduct structure (3). The extent to 
which the above methodology can be used to probe and classify the types of 
adducts formed from (+)- and (-)-anti-BPDE, is the principal focus of this work. 
Considerable progress on the elucidation of structurally different types of 
adducts has been made by Geacintov et al. (9, 10) and Kim et al. (11, 12) who 
have used a variety of spectroscopic techniques, including fluorescence quenching. 
It has also been shown that low and room temperature spectra of the adducts were 
qualitatively similar (12). The BPDE-DNA adducts have been classified as type I 
or n (11, 12). For the type I sites identified the aromatic plane of pyrene (the 
parent fluorescent chromophore) appears to be nearly parallel (within -25-30°) to 
the planes of the unmodified DNA bases. Such adduct sites may be viewed as 
interior (e.g., quasi-intercalated). Type n sites are characterized by a lower degree 
of interaction between the pyrenyl moiety and the bases and, therefore, may be 
viewed as exterior. As demonstrated by Geacintov et al. (9, 10), classification 
according to types I and n can be made on the basis of adduct accessibility to 
externally added fluorescence quenchers such as acrylamide. Such studies (11-13) 
have thus far identified only two types of adducts from each of the (+)- and 
(-)-anti-BPDE enantiomers. In this paper, the aforementioned methodology is used 
to identify, respectively, three and five adducts from these enantiomers. Two 
approaches are used to classify these adducts as type I or type 11 and are shown to 
yield consistent results. The first is based on fluorescence quenching, while the 
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second is based on the magnitude of the ratio (R) of the intensity of the 
fluorescence origin (0-0) band relative to the intensity of the prominent vibronic 
band - 1400 cm"' lower in energy. For pyrenyl chromophores this ratio has been 
shown to be sensitive to the polarity of the microenvironment of the chromophore 
(14-16). Kim et al. (12) have recently used R-values to classify BPDE-DNA 
adducts as type I or type n. 
The improved resolution of the fluorescence spectra (77 K) reported here is 
due primarily to the utilization of narrow line laser excitation at wavelengths 
chosen for optimum selectivity. High resolution 4.2 K line narrowed spectra 
provide important complementary data for classification of adducts as type I and 
type n. In particular, it is demonstrated that the degree of interior binding (strength 
of coupling between the pyrenyl-chromophore and the DNA bases) is accompanied 
by an increase in the transition electron-phonon coupling strength. A possible 
mechanism for this correlation is suggested. 
C. Experimental 
1. Instrumentation 
The underlying principles of FLNS and the associated instrumentation have 
been described in detail in several papers (17-20) and, thus, will not be reviewed 
here. Laser excited fluorescence spectra at 77 K, obtained under non-line-
narrowing conditions (S^ <— excitation) and excitation spectra (T = 4.2 K), were 
measured using a SRS Model SR280 boxcar averager equipped with two Model 
SR2S0 processor modules for channel A and B. Channel A was used to monitor 
the fluorescence signal, while channel B was used to monitor the pulse to pulse 
intensity jitter of the excimer pumped dye-laser. All spectra reported were 
normalized for pulse jitter. The boxcar averager was interfaced through a SR245 
88 
computer interface module with a PC compatible computer for data acquisition and 
analysis. 
. 2. Glasses 
The glass-forming solvent used was a mixture consisting of 50% glycerol, 
40% water, and 10% ethanol by volume. Quartz tubing (3 mm o.d. x 2 mm i.d. x 
2 cm) sealed at one end was used to contain samples (~ 30 (xl total volume). 
Experiments were performed with a double-nested 5 L glass liquid helium dewar 
equipped with quartz optical windows and designed to have no liquid nitrogen in 
the optical pathways (18). For 77 K studies, the same dewar was filled with liquid 
nitrogen. FLN and excitation spectra were obtained with the samples immersed in 
liquid helium, T = 4.2 K. Fluorescence spectra obtained under non-line-narrowing 
conditions were obtained at 77 K. 
3. Materials 
Calf thymus DNA was purchased from Worthington Chemicals (Freehold, NJ). 
The DNA was prepared and reacted with (+)-anti-BPDE or (-)-anti-BPDE as 
previously described by Geacintov (21). The BPDE enantiomers were purchased 
from the National Cancer Institute Chemical Carcinogen Reference Standard 
Repository. 
The modiGcation levels of the (+)- and (-)-anti-BPDE adducts studied were 
0.5% bases and 1.5% bases modified, respectively. The adducts were diluted in the 
glass forming solvent to a concentration (pyrenyl chromophores) of ~ 10'^ M. To 
preclude the possibility of erroneous assignments of spectral features of the tetraol 
of BPDE (BPT, a photo-degradation product of the DNA adducts) to DNA adducts, 
comparison spectra for (BPT + DNA) mixture were routinely obtained (spectra not 
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shown). The physical mixture was employed because it was determined that the 
energies of the Sj (lowest excited singlet), fluorescence origins for free BPT in the 
glass and the DNA mixture in the glass were slightly different. For the 
. fluorescence quenching studies, acrylamide (ACR) was employed at a concentration 
of - 1 M, an optimal concentration in such studies (13). 
D. Results and Discussion 
In this section data are presented which establish that three and five DNA 
adducts are formed from (+)-anti-BPDE and (-)-anti-BPDE, respectively. The 
adducts will be designated by (+)l-3 and (-)l-5. The convention adopted is that the 
Sj state energy (energy of the fluorescence origin) decreases with increasing 
number associated with the (+) or (-) adduct label. Since the order in which the 
adducts are identified does not correlate with these numbers, the reader may find it 
useful to refer to Table I before proceeding. This table lists the fluorescence origin 
wavelengths for the different DNA adducts as determined from the 77 K 
fluorescence spectra obtained with S2 <— laser excitation. Each adduct is 
classified as type I or type n in the table. 
1. Absorption spectra 
The absorption spectra of (+)-anti-BPDE-DNA adducts and 
benzo(a)pyrene-tetraol (BPT) are presented in Figure 1. The absorption spectrum 
of (+) adducts is red shifted (~ 2-3 nm) with respect to the absorption peak of BPT 
and exhibits a broad tail beyond 350 nm which is not observed for BPT. For the 
(-)-anti-BPDE-DNA adducts, the absorption spectrum is more diffuse and 
considerably red shifted, indicating that the (-) adducts may be more heterogeneous. 
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(+) anti-BPDE-DNA 
— — - (—) onti—BPDE—DNA 
BPT 
I 355\^ X 
300 320 340 360 380 
WAVELENGTH (nm) 
Figure 1. Typical absorption spectra at room temperature. : 
(+)anti-BPDÉ-DNA adducts, 1.3 jiM of bound chromophores, 0.26 mM 
DNA base concentration. —: (-)anti-BPDE-DNA adducts, 0.8 pM bound 
chromophores and 0.26 mM DNA base concentration. ••••: BPT (2.4 
pM), in buffer. Excitation wavelengths of 346 and 355 nm are indicated 
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2. Laser-exited fluorescence spectra at 77 K 
In this subsection, we explore the utility of 77 K fluorescence spectra obtained 
with $2 <— Sg excitation for the distinction between macromolecular adducts derived 
from (+)-anti-BPDE and (-)-anti-BPDE, and the different binding configurations 
associated with a given enantiomer. In this regard, it will become apparent that the 
origin or (0,0) transitions of the —> S „ fluorescence spectra are particularly 
useful. Although S2 <— excitation precludes line narrowing, and thermal 
broadening at 77 K is significant, the relatively broad fluorescence spectra still 
provide very useful information. In the following subsection, fluorescence 
quenching and FLN data are used to provide additional insights on the 
heterogeneity associated with BPDE-DNA adducts. 
Figure 2 shows the fluorescence spectra at 77 K for (-)-anti-BPDE-DNA (A), 
and (+)-anti-BPDE-DNA (B) obtained with = 346.0 nm. At 77 K, the 
fluorescence origin of BPT + DNA is located at 376.8 nm (spectrum not shown). 
The BPT fluorescence spectrum is readily distinguishable from those of the two 
adducts and no contamination of the adduct spectra by BPT could be discerned for 
= 346.0 nm. The (+)-anti-BPDE-DNA spectmm is dominated by a single 
adduct whose (0,0) band occurs at 378.0 nm (solid arrow). This adduct will be 
referred to as (+)1 in what follows, cf. Table I. The shoulder in spectmm C 
located at 380.6 nm (dashed arrow) will be assigned shortly to the origin band of 
another adduct (+)3, Table I. Inspection of spectrum A reveals that the adduct 
distribution from (-)-anti-BPDE is more heterogeneous with the highest energy 
origin at 378 nm (solid arrow). The corresponding adduct is denoted by (-)l. The 
dashed and dotted arrows indicate the possible existence of additional 
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A (-) ontl-BPDE-DNA 
B (+) ontî-BPDE-DNA 
ex 345nm 
370 390 410 430 
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Figure 2. Laser-excited fluorescence spectra. (-)anti-BPDE-DNA (A) and 
(+)anti-BPDE-DNA (B). Gate delay (GD) = 30 nsec, gate width (GW) 
70 nsec; = 346 nm, T = 77 K 
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adduct origins in the ~ 380-387 nm region. 
The wavelengths of the adduct fluorescence origins serve as good 
approximations for the energies or wavelengths of the Sj <— absorption origins, 
Table I. Since the Sj energies are different, the relative intensities of different 
adducts derived from a specific enantiomer should depend on Figure 3, 
through comparison with Figure 2, illustrates this point. Spectrum B in Figure 3 
reveals that = 355 nm excitation leads to a marked increase in the intensity of 
the 380.6 nm origin fluorescence spectrum (dashed arrow. Figure 3B), thus 
confirming its assignment to a unique adduct, (+)3. At the same time, the origin 
intensity of (+)1 (solid arrow in Figure 2) is greatly diminished. The weak 
shoulder in spectrum B of Figure 3 indicated also by a solid arrow may be due to a 
trace of BPT and/or (+)1. Comparison of spectra A in Figures 2 and 3 also shows 
that = 355 nm leads to a significant decrease in the fluorescence origin intensity 
of the (-)l adduct. As a result, an adduct with a fluorescence origin at ~ 380.6 nm 
is revealed. This adduct is denoted as (-)3. Furthermore, spectrum A of Figure 3 
reveals that a third (-)-type DNA adduct does exist with an origin located at ~ • 
385-386 nm (dotted arrow). It is designated as (-)5. Its possible existence is also 
suggested in spectrum A of Figure 2 (dotted arrow). A more exact determination 
of the location of the (-)5 origin will be made in the following subsection. Our 
gated detection studies revealed no significant differences in the fluorescence 
lifetimes of the adducts identified from Figures 2 and 3. 
94 
A (-)anti-BPDE-DNA 
B (+)antî—BPDE—DNA 
ex 355 nm 
400 420 
WAVELENGTH (nm) 
Figure 3. Laser-excited fluorescence spectra. (-)anti-BPDE-DNA (A) and 
(+)anti-BPDE-DNA (B). GD = 30 nsec, GW = 70 nsec, = 355 nni, 
T = 77 K. The solid arrow indicates possible contribution due to a trace 
of BPT and/or (+)1 
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3. FLN spectra and fluorescence quenching DNA adducts formed from 
(+)-anti-BPDE 
Geacintov et ai. (9, 10) have utilized fluorescence, linear dichroism, and 
- fluorescence quenching to classify DNA binding sites as type I (interior) or type II 
(exterior). Quasi-intercalated or pyrene-DNA base stacking sites are of the former 
type, and are expected to be significantly less accessible to solvent or fluorescence 
quenchers (such as acrylamide) than type H sites for which the pyrenyl moieties are 
located at exterior regions of the DNA double helix. 
From the results of Ref. 12, it would appear that the 378 nm (+)1 adduct, vide 
supra, corresponds to a type n site with binding at N^-dG. Figure 4 provides 
support for this assignment. Spectrum A for (+)-anti-BPDE-DNA + ACR 
(acrylamide) was obtained with = 346 nm which, in the absence of quencher, 
yields (+)1 as the dominant contributor to the fluorescence, see spectrum B of 
Figure 2, Comparison of the latter spectrum with spectrum A of Figure 4 reveals 
that (+)1 is significantly quenched by ACR (although its fluorescence origin is still 
observable, see dotted arrow). The fluorescence origin in spectrum A (solid arrow) 
at 379.3 nm is assigned to a minor adduct, (+)2, which is apparently significantly 
less quenched than the (+)1 adduct. Spectrum B of Figure 4 for (+)-anti-BPDE-
DNA was obtained with = 355 nm in the presence of the quencher. In the 
previous subsection, it was shown that this excitation is selective for the (+)3 
adduct at 380.6 nm. Spectra B of Figures 3 and 4 are very similar and our 
intensity measurements indicate that (+)3 is not significantly quenched by ACR. It 
is assigned as a type I site. 
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(+)anti-BPDE-DNA + ACR 
A ex 346 nm 
B ex 355 nm 
m 
LU O 
2 
o to 
LU 
420 380 400 
WAVELENGTH (nm) 
Figure 4. Laser-excited fluorescence spectra of (+)anti-BPDE-DNA in the presence 
of 1 M acrylamide. Spectra A and B were obtained for = 346 nin 
and = 355 nm, respectively. GD = 30 nsec, GW = 20 nsec, T = 77 
K 
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m 
362 384 
WAVELENGTH (nm) 
Figure 5. FLN spectra of BPDE-DNA adducts for vibronic excitation: (A) and (B) 
obtained with = 369.6 nm for (+)anti-BPDE-DNA' and 
(-)anti-BPDE-DNA, respectively; spectrum (C) for (-)anti-BPDE-DNA, 
Xçjj = 373.9 nm. Bands are labeled according to excited-state vibrational 
frequencies (cm'^), T = 4.2 K 
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Frame A of Figure 5 is a portion of the FLN spectrum of (+)-anti-BPDE-DNA 
obtained with Aex = 369.6 nm and in the absence of quencher. The sharp zero-, 
phonon lines (ZPL) are labeled with excited state (S^) mode frequencies (in cm'*). 
" This vibronically-excited FLN q)ectrum is identical to that of the major (+) adduct 
(N^-dG) reported earlier (18). The excitation wavelength of 369.6 nm is located 
about 600 cm"^ higher in energy than the zero-point level of Sj for (+)1 and, 
therefore, yields the excited state mode frequencies in the vicinity of 600 cm"^ (18). 
Frames B and C, for (-)-anti-BPDE-DNA, are shown for comparison and will be 
discussed in the following subsection. 
We next explore the utility of combining quenching with FLNS. Figure 6 
shows the FLN spectra for (+)-anti-BPDE-DNA with (A) and without (B) quencher. 
Comparison of A with BPT spectra shows that released BPT does not contribute to 
spectrum A for = 371.6 nm. Although for this excitation wavelength the major 
(+)1 adduct makes a significant contribution to the ZPL of spectrum A, a 
comparison of this spectrum with spectrum B indicates that a second adduct also 
contributes. This follows, since the relative intensities of the ZPLs in q)ectrum A 
are changed by the addition of the quencher. For example, compare the relative 
intensities of the bands near 463 and 580 cm"^ (the experimental uncertainty in our 
frequency measurements is ± 3 cm"^) in A and B. With reference to Table I, we 
conclude that the (+)2 adduct contributes to the ZPLs of spectrum A and more 
signifrcantly to the 579 cm"' band than the lower frequency bands, since the 
frequency difference between and the state of (+)2 is - 560 cm''. In the 
same way, it follows that the (+)1 adduct makes a greater contribution to the bands 
in the vicinity of 462 cm"' since the pertinent state energy gap is ~ 470 
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cm"'. Since (+)1 undergoes significant quenching while (+)2 does not (yide infra), 
the bands in the vicinity of 462 cm"' should undergo a greater degree of quenching 
than the 579 cm"' band. This is consistent with the results of Figure 6. We do not 
believe that the (+)3 makes a signiHcant contribution to the ZPLs in Figure 6, since 
its fluorescence excitation spectrum does not predict sharp fluorescence ZPLs, vide 
infra. 
Thus far, three (+)-anti-BPDE-DNA adducts have been identifîed, (+)1 - (+)3, 
and (+)1 and (+)3 classified as sites n and I, respectively. Based on our available 
data, a fîrm classification cannot be made. However, because (+)2 is intermediate 
in energy between (+)1 and (+)3, one might postulate that the (+)2 site is located 
more in the interior than (+)1 but not to the same degree as (+)3. Figure 7 
provides some support for this. Spectra 1-3 are high resolution fluorescence 
excitation scans obtained for fluorescence detection (5 cm"' detection band pass) at 
381.0, 379.5, and 378.5 nm, respectively. Notice from Table I that these 
values should be selective for the (+)3, (+)2, and (+)1 adducts of 
(+)-anti-BPDE-DNA, respectively. Spectrum 3 (no ACR) reveals that the (+)1 
excitation spectrum is dominated by sharp ZPLs and, therefore, that its linear 
electron-phonon coupling is weak. The spectrum is contaminated by a few BPT 
bands which are likely the result of photo-degradation of the DNA adducts. The 
fluorescence excitation spectrum of the BPT + DNA standard mixture is also 
characterized by pronounced ZPL and weak coupling (spectrum not shown). 
Spectra 1 and 2 of Figure 7 were obtained in the presence of ACR. Spectrum 1 for 
(+)3 with its weak ZPL structure and intense and broad envelope provides a sharp 
contrast to spectmm 3 for (+)1. 
100 
w 
o 
o 
O 
ai 
g 
è 1 
A) 
§ 
s 
A 8 " / jV m ml 
B) 
377 378 379 380 381 382 
WAVELENGTH (nm) 
Figure 6. Comparison of FLN spectra. (+)anti-BPDE-DNA (A) and 
(+)anti-BPDE-DNA in the presence of ~ 1 M acryiamide (B). 
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Figure 7. Fluorescence excitation spectra of (+)anti-BPDE-DNA. Spectra 1 and 2 
obtained with 1 M acrylamide; spectrum 3 obtained in absence of 
quencher. Spectra 1-3, obtained with = 381 nm, 379.5 nm and 
378.5 nm (bandpass - 5 cm*^), respectively (see text). Spectra are 
arbitrarily shifted for clarity. Peaks are labeled with excited-state 
vibrational frequencies Bands labeled by T are due to BPT. T = 4.2 K 
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We interpret the difference in terms of stronger electron-phonon coupling for 
the (+)3 adduct and suggest that this increase, in coupling strength may be due to an 
increase in the charge-transfer (CT) character of the S j state resulting from a 
stronger interaction between the pyrenyl moiety and the DNA bases for the type I 
site. We have studied this effect for pyrene with FLN (unpublished data) and 
shown that the red shift for the Sj state of pyrene produced by intercdation into 
DNA is accompanied by an increase in the electron-phonon coupling strength. 
Furthermore, it is firmly established that the CT states of 1:1 7C-molecular 
charge-transfer complexes are characterized by veiy strong coupling (22). With the 
observation that spectrum 2 of Figure 7 for (+)2 is intemiediate in nature between 
spectra 1 and 3, the following conjecture emerges: the decrease in solvent or 
quencher accessibility which reflects the degree of interior binding is accompanied 
by a decrease in the state energy and a concomitant increase in the 
electron-phonon coupling strength (CT character). We proceed to further test this 
notion with the results for the (-)-anti-BPDE-DNA adducts and, in the following 
subsection, through consideration of the R-values for all the adducts. 
4. DNA adducts formed from (-)-anti-BPDE 
Before considering the fluorescence quenching results for (-)-anti-BPDE-DNA, 
we compare its FLN spectrum for = 369.6 nm, spectrum B in Figure 5, with the 
corresponding FLN spectrum for (+)-anti-BPDE-DNA, spectrum A, which is mainly 
due to the (+)1, N^-dG adduct. The ZPLs such as 547, 583, 648, and 757 cm"^ in 
spectrum B are most reasonably assigned to (-)l and (-)2, since their fluorescence 
origins lie close in energy to that of (+)1, Table I. It will become apparent that the 
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onset of the broad underlying fluorescence in spectrum B, upon which the 757 cm"' 
ZPL is superimposed, is due to the (-)3 adduct. The spectrum in the bottom frame 
of Figure 5 is that of (-)-anti-BPDE-DNA obtained with = 373.9 nm and, as 
expected, its ZPL intensity distribution is different than the distribution in spectrum 
B obtained with = 369.6 nm. The contribution of (-)l adduct to spectrum C is 
negligible, since the center of the observation window at ~ 383 nm was chosen to 
be selective for the (-)4 adduct (identified in the following subsection, cf. Table I). 
A similar FLN spectram was observed for the observation window at ~ 385 nm, 
selective for (-)5. We believe, therefore, that (-)4/5 are the major contributors to 
the ZPLs of spectrum C. 
Figure 8 shows three laser excited 77 K fluorescence spectra for 
(-)-anti-BPDE-DNA in the presence of quencher. Comparing the origin region of 
spectrum A (X^^ = 346 nm) with the same for spectram A of Figure 2 (the same 
no quencher) reveals that the origin in the latter spectram at 378 nm (solid 
arrow) due to (-)l is markedly suppressed by ACR. Thus (-)l, like (+)1, can be 
assigned as a type n site. Spectram C of Figure 8 for = 355 nm is very similar 
to spectrum B of Figure 4 and is due to the (-)3 adduct at 380.6 nm (solid arrow), 
which is not subject to quenching. Therefore, it is assigned as a type I (interior) 
site. Note that the contribution from (-)l to spectram C of Figure 8 is rendered 
negligible because of ACR quenching and the value of X^^ = 355 nm (see 
preceding subsection). All spectra presented thus far were obtained with a 30 ns 
gate delay. The adducts determined thus far have similar lifetimes (- 120 ns, based 
on comparisons of spectra obtained with 0, 30, and 100 ns gate delays). We have 
encountered only one instance where this is not the case. 
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Figure 8. Laser-excited fluorescence spectra of (-)-anti-BPDE-DNA in the presence 
of 1 M aciylamide. Spectra A and B were obtained with = 346 nm 
and GD times of 30 nsec and 100 nsec, respectively. Spectrum C was 
obtained for = 355 nm and a GD of 30 nsec (see text). T = 77 K 
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Figure 9. FLN spectra of the (-)-anti-BPDE-DNA. Absence (A) and presence (B) 
of quencher; T = 4.2 K, = 356.9 nm, GD = 30 nsec, GW = 20 nsec. 
FLN peaks are labeled with their excited-state vibrational frequencies 
. (cm'b 
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Specûum B of Figure 8 was obtained with = 346 nm for a gate delay of 
100 ns and should be compared with spectrum A of the same figure. It is apparent 
that the contribution from (-)3 to the origin region of spectrum A has been 
effectively eliminated in spectrum B which reveals, however, the existence of 
another longer lived (-) adduct whose origin band (dotted arrow) lies at 379.3 nm. 
It is denoted by (-)2 and has an energy which is approximately equal to that of 
(+)2, Table I. 
Figure 9 shows the FLN spectra for a relatively high Sj excitation energy 
= 356.9 nm) in the absence (A) and presence (B) of quencher. It should be noted 
that (18) the active mode frequency range (width of 200-300 cm"') probed for each 
adduct is approximately centered at a frequency determined by the difference in 
frequency associated with and the frequency of the adduct absorption 
(fluorescence) origin. Table I. This central frequency for (-)5 is ~ 2100 cm"^ At 
such a. high excess vibrational energy above the zero-point level of Sj, vibrational 
congestion for active modes is quite severe and, as a result, FLN is largely 
precluded. It is reasonable to suggest that the broad unstructured fluorescence in 
spectrum A, which has an onset near 383 nm, is due to (-)5 as well as (-)4 and (-)3. 
This is consistent with the marked reduction of the broad fluorescence produced by 
the addition of quencher (spectrum B). Except for the 1440 cm"^ band, which we 
have confirmed is due to BPT, the labeled ZPLs in spectmm B are believed to be 
predominantly due to (-)2 since the (-)l adduct is to a large extent quenched (along 
with (-)4/5). The (-)3 type I adduct is likely to make its major contribution to the 
underlying broad fluorescence of spectrum B. 
Fluorescence excitation spectra for the (-) 1, 2, and 3 adducts were obtained 
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under high resolution conditions. The excitation qjectra in Figure 7 and those for 
the above (-) adducts (not shown) are quite similar. Thus, the discussion presented 
earlier for Figure 7 need not be repeated. Suffice it to say that the linear 
" eiectron-phonon coupling strength increases in the order (-)l, (-)2, and (-)3 and in 
parallel to the degree of interior binding. 
5. Binding site classification based on the fluorescence intensity ratio R 
In this subsection, we exploit the fact that the ratio R of the intensity of the 
origin band relative to the prominent vibronic band at ~ 1400 cm'^ (near 400 nm in 
our spectra) of the pyrenyl moiety in the DNA adducts (and BPT) is very sensitive 
to the solvent-cage polarity (11, 12), thus mimicking the well-known behavior of 
pyrene itself (14-16). This solvent-chromophore induced effect is expected for 
weakly allowed electronic transitions, such as Sj <— for pyrene; the low molar 
extinction coefficient is due to the near cancellation of two transition dipoles 
associated with the two single-electron excited electronic configurations whose 
interaction determines the Sj state wavefunction. To our knowledge, however, an 
adequate theoretical treatment of the polarity dependence of the factor R for pyrene 
does not exist. In what follows, we are guided by earlier work which indicates that 
R increases with increasing solvent-cage polarity. For DNA adducts dissolved in 
the glycerol/H20 based glass, one expects that R should increase with increasing 
solvent accessibility. Therefore, type n sites should exhibit higher R-values than 
type I sites. 
Since the adducts from (+)-anti-BPDE are the less heterogeneous, with (+)1 
being the dominant adduct, we consider these adducts first. That the (+) adducts 
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exhibit a relatively small heterogeneity, and that the major adduct is type H, have 
been previously established (12, 13). The R-values of 1.75, 1.25, and 1.15 given in 
Table n for (+)1, (+)2 and (+)3 were measured directly from spectmm B of Figure 
2, spectrum A of Figure 4, and spectrum B of Figure 3, respectively. The last 
spectrum for (+)3 appears to be "pure" and was used to correct the R-value for (+)1 
whose spectrum in Figure 2 is contaminated by a small contribution from (+)3 (see 
dashed arrow of spectrum B in Figure 2). The corrected value is 1.9 and is given 
in parenthesis in Table H. Also included in Table n is the R value for the (BPT + 
DNA) mixture. The relative magnitudes of R for (+)1 and (+)3 are consistent with 
our earlier conclusion that they are type n and I, respectively. The value of 1.25 
for (+)2 is only slightly higher than for (+)3, suggesting that it may also be a type I 
site. 
Analysis of the R-factors for the adducts from (-)-anti-BPDE is more difficult 
because of the presence of 5 adducts, (-)j (j = 1-5). Nevertheless, the improved 
resolution of the laser excited 77 K fluorescence spectra (with and without a 
quencher) has enabled us to determine the values given in Table H.. Some 
discussion of the analysis procedure is appropriate. From spectra A of Figures 2 
and 3, one estimates that Rg^g = 0.85 < R355 = 1.15, where the subscript on R 
denotes the laser excitation wavelength. This would appear to be in contradiction 
to our earlier conclusion, vide supra, that = 355 nm is quite highly selective for 
quasi-intercalated or pyrene-base stacking type adducts. However, this 
contradiction does not exist when appropriate deconvolution of overlapping spectral 
features from difrerent adducts is taken into account. Our own, and previous results 
(12-13), indicate that type I sites are important for the (-)-anti-BPDE-DNA adducts. 
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The value of R ~ 1.1 in Table H for (-)2 was obtained directly from spectrum B of 
Figure 8, but it may be higher since spectrum B contains a contribution from (-) 3 
adduct. The (-)2 adduct is a minor adduct which is observable only in the presence 
of the quencher and for a longer fluorescence gate delay (100 ns). Thus, to a first 
approximation, its contribution to the spectrum of (-)l in Figure 2(A) is taken to be 
negligible. The R-value of 0.9 for (-)3 was measured from spectrum C of Figure 8 
(Xg^ = 355 nm with quencher). This spectrum was then appropriately weighted and 
subtracted from spectrum A of Figure 3 to yield the spectmm for (-)5 (not shown) 
which was used to determine R 1.8, Table H. To determine the R-value for (-)l, 
the (-)3 and (-)5 spectra were appropriately scaled and subtracted from spectrum A 
of Figure 2. This procedure yielded the spectrum shown in Figure 10. Spectra A 
of Figures 2 and 8 had led to a tentative assignment of a fifth adduct (-)4, cf. 
Table I, with a fluorescence origin near 382 nm. The appearance in Figure 10 of a 
fluorescence origin at 382.7 nm makes this assignment firmer. Taking into account 
the minor overlap between the (-)l and (-)4 spectra, Figure 10 provides R values of 
1.6 and 1.7 for (-)l and (-)4, respectively. The uncertainty for these values is 
estimated at ± 0.1. 
The results discussed in the two previous subsections showed that both (+)1 
and (-)l are readily quenched while (+)3 and (-)3 are not subject to quenching. 
Although not specifically discussed, the spectra (77 K) indicate that (-)2 and (+)2 
are not subject to significant quenching (note, for example, that (+)2 was identified 
by spectrum A of Figure 4 obtained with quencher) but that (-)4 and (-)5 are. The 
R values in Table n are in accord with the quenching behaviors of the adducts; 
namely, adducts (type H) which are quenchable are characterized by high 
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Figure 10. Deconvolved fluorescence spectrum for (-)l and (-)4 adducts. Dashed 
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R-values (~ 1.6-1.8) while those which are not have low values (0.9-1.25). On the 
other hand, the earlier mentioned hypothesis that solvent (quencher) accessibility 
decreases as the Sj state energy decreases is not in accord with the data for (-)4, 
• and decreases as the S ^ state energy decreases is not in accord with the data for 
(-)4 and (-)5 (both of which possess a high A-value). Spectrum C of Figure 5 (and 
other spectra, not shown) suggest that the (-)4/5 type adducts are characterized by 
quite prominent ZPLs, consistent with weak electron-phonon coupling. 
E. Concluding Remaries 
Our results are in agreement with those of earlier studies which showed that 
the DNA adducts derived from (-)-anti-BPDE are significantly more heterogeneous 
than those derived from (+)-anti-BPDE (23, 24), and that the (+)-adducts are 
dominated by type n binding sites, while the (-)-adducts also are characterized by 
significant contributions from type I binding sites (12, 13). However, contraiy to 
the conclusion of Ref. 12, our studies indicate that the (-)5 adduct (with 
fluorescence origin at - 385 nm) is type H. Since the fluorescence lifetimes of the 
(+)-adducts at cryogenic temperatures are similar, we estimate from the q)ectral 
data that the (+)l-N^-dG type II (exterior) adduct constitutes about 85% of the 
stable macromolecular adducts formed at the damage levels employed. The 
remaining two adducts, (+)2 and (+)3, are type I and are presumably of the 
quasi-intercalated and intercalated type. For the high DNA damage levels 
employed, the (+)2 and (+)3 adducts contribute only 15% of the total binding. 
However, when the damage level is very low (~ 1:10® modified bases), the relative 
contribution of (+)3 adduct significantly increases {cf. Chapter AC). That is, the 
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adduct distribution may depend on the damage level. Since in vivo DNA damage 
levels are very low and it is difficult to determine the relative efficiencies for repair 
of adduct sites from a given stereoisomer of a metabolite, it is important to develop 
" macromolecular analysis techniques of appropriately high selectivity and sensitivity. 
The results presented do not permit further structural characterization of the 
(+)j (j = 1-3) adducts. However, very recent results obtained for synthetic 
(+)-anti-BPDE-polynucleotide adducts indicate that (+)j (j = 1-3) are due to binding 
at a nucleophilic center of guanine (c/. Appendix B). 
The similarity between the Sj state energies and fluorescence spectra of the 
(-)l-3 and (+)l-3 adducts is very striking and suggests a correspondence between 
the nature of the base modified and the site of binding on that base. Thus, for 
example, (-)l may be the N^-dG analogue of (+)1. However, the adduct 
distributions from (+)- and (-)-anti-BPDE are very different. We conclude that the 
major adducts for the latter are (-)l and (-)3 with a relative weight of ~ 70-80%. 
The (-)3 adduct is type I which to a large extent, dominates the absorbance and 
linear dichroism spectra of the (-)-BPDE-DNA adducts (13). In contrast, the 
adducts from the (+) enantiomers are predominantly type H. It is interesting to note 
that both enantiomers are reasonably mutagenic in the repair-deficient salmonella 
typhimurium tester strains, while the (+)-enantiomer is markedly more mutagenic in 
repair-competent mammalian v79 cells, as well as being the only tumorigenic 
isomer in mice (23-26). For these reasons it has been speculated that the 
intercalated or quasi-intercalated type I adducts possibly are more readily repaired 
due to their marked increase in the distances between adjacent base pairs in the 
double helix (27). The methodology presented here has the potential for 
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distinguishing between adduct confonnations in DNA and for monitoring the fates 
of different adducts as a function of time in repair-competent cells. 
Finally, we remark that the nature of .the (-)4 and (-)5 adducts poses an 
interesting problem, since they are type n (exterior) and yet possess Sj state 
energies lower than those of the type I adducts. One possible explanation is that 
the former adducts are associated with a base other than guanine, for example, 
adenine. Another is that they are associated with binding to a nucleophilic center 
of guanine other than N^. Still, another would emerge were the Sj state energies of 
chemical adducts to be dependent on DNA base composition and sequence. We are 
currently investigating the latter possibility through studies on (+)- and 
(-)-anti-BPDE adducts formed from synthetic polynucleotides of specific base 
composition and sequence. Thus far these studies have shown, for example, that 
the (-)5 adduct exhibits base pair selectivity for alternating (dG-dC). We are 
encouraged to think that the study of adducts formed from synthesized 
polynucleotides will lead to further insights on the structures of the macromolecular 
adducts. 
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Table I. Spectral characteristic of (+) and (-) BPDE-DNA adducts at T 77 K 
(+) adducts (-) adducts 
fluorescence site fluorescence site 
band max. type band max. type 
(nm) (nm) 
(+)1 378.0 n (-)l 378.0 n 
(+)2 379.3 (-)2 379.3 I" 
(+)3 380.6 I (-)3 380.6 I 
(-H 382.7 n 
(-)5 385.2 n 
^ We assign (+)2 and (-)2 as site I type adducts with a "degree" of interior 
binding that is less than that for (+)3 and (-)3. 
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Table U. Summary of R ratios 
^ex W) R (nm) R 
(-)l 346 1.60 
(BPT+ 345 1.8" 
DNA) 
(-)2 346 -l.l'' 
(+)1 346 1.75 (-1.9) (-)3 355 0.90 
(+)2 346 ~ 1.25 (-H 346 1.7 
(+)3 355 1.15^= (-)5 355 1.8 
® For = 355 nm, the qjectnim of BPT-DNA complex consists of 
two bands at ~ 376.8 and 381 nm with R ratio 1.8 and 1.36, respectively. 
The physical nature of BPT-DNA complex wiU be discussed elsewhere (cf. 
Appendix B). 
^ This value could be slightly higher since spectrum B in Figure 14 
. may contain a contribution from (-)3 adduct. 
® This value could be smaller if corrected for possible contribution 
due to a trace of BPT and/or (+)1 (see Figure 8, curve B). 
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m APPENDIX B: PAPER H. A COMPARATIVE LASER 
SPECTROSCOPIC STUDY OF DNA AND POLYNUCLEOTIDE 
ADDUCTS FROM (+)-ANTI-DIOL EPOXIDE OF BENZO[a]PYRENE 
A. Abstract 
Fluorescence line narrowing spectroscopy in combination with fluorescence 
quenching and 77 K laser excited fluorescence spectroscopy is shown to be a 
powerful approach for characterization of chemically and/or structurally different 
adducts of (+)-anti-BPDE formed from DNA and the synthetic polynucleotides. 
Three polynucleotide duplexes ((poly(dG-dC)poly(dG-dC), poly(dG)-poIy(dC), 
poly(dA-dT)poly(dA-dT)) and single strand poly(dG) were used in this study, and 
the spectral characteristics and the quenchability of each corresponding adduct were 
elucidated. Of these it is the alternating poly(dG-dC)poly(dG-dC) that yields (+)-
1 and -2 adducts which are most similar to the trans N^-dG adducts of DNA. 
Fluorescence experiments with trans and cis standards of N^-dG from (+)-anti-
BPDE and guanine monophosphate were the bases for this stereochemical 
assignment. The model (+)-anti-BPDE adducts of the oligonucleotide 
d(ATATGTATA) were studied spectroscopically, and the results further confirm 
our previous conformation assignment of (+)-l as a type II adduct and (+)-2 as a 
quasi-intercalated adduct, and indirectly supports (+)-3 as an intercalated adduct. In 
addition, the FLN spectra of (+)-anti-BPDE-DNA reveal a new minor adduct, (+)-4, 
which is assigned as N^-dA on the base of the spectra of standard (+)-anti-BPDE-
poly(dA-dT)poly(dA-dT). Finally, the 77 K fluorescence spectroscopy revealed 
three different species of racemic anti-BP tetraol which has been physically mixed 
121 
with DNA and poly(dG), and their spectral characteristics and the quenchability are 
also presented, which will be greatly conducive to the spectral analysis of "real 
adducts". 
B. Introduction 
The mutagenic and tumorigenic properties of polycyclic aromatic 
hydrocarbons (PAH) have been the subjects of numerous studies (1-3). 
Benzo[a]pyrene (BP) has been most extensively studied and provides an important 
testing ground for models of DNA-metabolite physical and chemical interactions, 
mutagenesis and tumorigenesis. The physico-chemical properties of DNA adducts 
from and the biological effects of BaP have been recently reviewed by Geacintov 
(4, 5) and Graslund and Jemstrom (6). The metabolic pathways (diol epoxide and 
one-electron oxidation or radical cation (7, 8)) of BaP and base-nucleophilic center 
specificity of its electrophilic metabolites are rather well understood. However, the 
relationships between base-metabolite chemical stmcture, site structure and genetic 
mutation (e.g., of proto-oncogenes) or error-free and -prone DNA repair are not 
(4-6, 9-12). Thus, the problem of base sequence specificity for metabolites should 
receive greater attention. This also pertains to the relevance for intact mammalian 
cells of the structural and dynamical properties of the adducts observed in vitro 
with pure DNA. 
Solution of such problems will depend, in part, on the availability of highly 
selective and sensitive bioanalytical methodologies for the characterization of both 
stable and labile covalent DNA-PAH adducts. The required selectivity is well-
illustrated by noting that the primaiy diol epoxides of BaP which react with DNA 
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are (+)-trans-7,8-dihydroxy-anti-9,10-epoxy-7,8,9,10-tetrahydro-BP ((+)-anti-BPDE), 
(-)-anti-BFDE and their syn-diastereomers, Figure 1. Moreover, each stereoisomer 
yields a distribution of adducts, vide infra. For studies of DNA from mammalian 
- cells exposed to ambient concentrations of PAH the required detection limit for 
adducts is about 1 femtomole. Techniques that allow for the analysis of intact 
macromolecular DNA are particularly attractive for a number of obvious reasons. 
At present, the highest resolution frequency domain technique available for the 
analysis of DNA-PAH adducts is laser-excited fluorescence line narrowing 
spectroscopy (FLNS) (13-21). FLNS is also applicable to nucleotide and 
nucleoside adducts (7, 21). Most recently, this technique has been used for analysis 
of macromolecular DNA and globin damage from in vivo exposure to PAH (20, 
22). For example, it was shown that the major stable DNA adduct from the liver of 
fish exposed to high dosage levels of BaP is derived from syn-BPDE (20), in 
agreement with previous work (23). At low dosage levels the major adduct was 
found to originate from (+)-anti-BPDE (23, 24). FLNS was used to prove that (22) 
the major human globin adduct from BaP is a carboxylic ester and that this adduct 
is of the interior type (i.e., undetectable by monoclonal anti-body approaches). 
Analyses by FLNS of the urine and feces of rats treated with BaP has proven, for 
the first time, that the cytochrome P-450 catalyzed one-electron oxidation of BaP is 
a major pathway for DNA damage in mammalian cells (25). The nucleotide adduct 
identified was BaP bound at its C® position to N^ of guanine. Distinction by FLNS 
between this adduct and that formed at of guanine had been demonstrated earlier 
(17). 
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(+)- anti - 7,8 - dihydrodiol 
9,10-epoxide 
(-) - anti - 7,8 - dihydrodiol 
9,10-epoxide 
Figure 1. Structures of anti-BPDE stereoisomers and associated cis and 
trans tetraols 
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However, we recently reported that FLNS in combination with fluorescence 
quenching and 77 K selectively excited (Sg <— S^) fluorescence spectroscopy is a 
more powerful methodology for DNA adduct analysis (19). In this work five ((-)-j, 
j = 1-5) adducts from the reaction of (-)-anti-BPDE with purified DNA were 
identified and classified as type I (interior or quasi-intercalated) or type II (exterior, 
solvent accessible). The (+)-anti-BPDE enantiomer yielded three adducts with (+)-l 
dominant at - 85%, Table I. That the (-)-enantiomer yields the more heterogeneous 
distribution of adducts was known from earlier work (26, 27). It is important for 
the present paper to note also that type n adducts are characterized by a higher 
value for the ratio (R) of the intensity of the fluorescence origin to that of the 
prominent vibronic band at - 1400 cm"^ That is, the more hydrophobic the 
environment of the pyrenyl chromophore the lower the R-value. With increasing 
hydrophobicity the linear electron-phonon coupling increases; for example, line 
narrowing in fluorescence or fluorescence excitation was not observed for the quasi-
intercalated and solvent inaccessible (+)-3 and (-)-3 adducts (19). The strong 
coupling is presumably the result of a strong interaction between the pyrenyl 
chromophore and the bases, which imparts significant charge-transfer character to 
the Sj state. On the basis of FLN spectra both (+)-l and (-)-l were assigned as 
N^-dG-BPDE adducts. The (-)-4 and -5 species were suggested to be due to 
adducts of BPDE with a base(s) other than guanine, for example, adenine. 
Unavailability of appropriate standard adducts prevented more definitive 
assignments. 
The results of Ref. (19) suggest that the above methodology should prove 
useful for the study of DNA repair and base sequence specificity of covalent 
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binding. It is the latter application that the present paper deals with. Specifically, 
we report the results of studies on adducts formed from (+)-anti-BPDE with the 
alternating co-polymers poly(dG-dC)-poly(dG-dC) and poly(dA-dT) 'poly(dA-dT) 
and non-alternating poly(dG)'poly(dC) as well as single strand poly(dG) and the 
oligonucleotide d(ATATGTATA). Detailed comparisons of their fluorescence 
spectra, fluorescence quenching and other properties with those of 
(+)-anti-BPDE-DNA adducts are given in order to gain some insight about base 
sequence specificity. In addition, the fluorescence spectra of the trans and cis 
isomers of the adduct formed from guanine-monophosphate and (+)-anti-BPDE are 
used to assign the stereosymmetry of the (+)-l and -2 DNA adducts. A fourth 
minor DNA adduct from (+)-anti-BPDE, (+)-4-DNA, is identified and assigned as 
N^-dA (type II). 
C. Experimental 
1. Instrumentation 
The underlying principles of the low temperature (4.2 K) FLNS and the 
associated instrumentation have been described in detail (13). The excitation source 
was a Lambda Physik FL-2002 dye laser pumped by a Lambda Physik EMG 102 
MSG excimer laser. Typical intensities used for the FLNS (4.2 K) and S2 S^ 
(77 K) laser excited experiments were - 3 and - 30 mW/cm^, respectively. 
Fluorescence was detected with a Princeton Instruments IRY-1024 intensified 
blue-enhanced gateable photodiode array. Gated detection was accomplished using 
a Lambda Physik EMG-97 zero-drift controller to trigger a FG-100 high voltage 
gate pulse generator which provides adjustable delay and width of the detector's 
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temporal observation window. 
Laser excited fluorescence spectra at 77 K, obtained under non-line-narrowing 
conditions (82 <— excitation) were measured using a SRS Model SR280 boxcar 
averager (Stanford Research) equipped with two Model SR250 processor modules 
for channel A and B. Channel A was used to monitor the fluorescence signal, 
while channel B was used to monitor the pulse to pulse intensity jitter of the 
excimer pumped dye laser. All spectra reported were normalized for pulse jitter. 
The boxcar averager was interfaced through a SR245 computer interface module 
with a PC compatible computer for data acquisition and analysis. 
The delay time for fluorescence measurements was 25 ns and the width of the 
observation window wa 60 nsec. Samples were dissolved in 30 (iL of 5:4:1 
glycerol-HgO-EtOH in quartz tubes, taken through several freeze-pump-thaw 
degassing cycles, sealed, cooled to 4.2 K. 
2. Materials 
Calf thymus DNA was purchased from Worthington Chemicals (Freehold, 
NJ). The DNA was prepared and reacted with (+)-anti-BPDE or (-)-anti-BPDE as 
described previously (28, 29). The BPDE enantiomers were purchased from the 
NCI Chemical Carcinogen Reference Repository. The synthesis and purification of 
the polynucleotides poly(dG-dC)poly(dG-dC), poly(dA-dT)poly(dA-T), 
poly(dG) poly(dG) and d(ATATGTATA) is described elsewhere (30, 31). For all 
adducts studied (incl. DNA) the % modification levels fell in the range 0.2-1.5, 
except for poly(dG) for which the level was 0.03. The synthesis of the adducts 
from (+)-anti-BPDE and guanine monophosphate and the isolation procedure for the 
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trans and cis isomers is given in Ref. (32). For all reaction products extreme care 
was taken to remove physically bound tetraols (33). The adducts were diluted in 
the glass forming solvent to a pyrenyl chromophore concentration of - 10"^ M. 
For formation of physical adducts BPT (50 ^1, 4 x 10"^ M) was mixed with 
DNA or poly(dG) (50 ^1, 1 mg/ml). The mixture was sonicated for 5 min at 20 °C 
twice. Then, 150 pi of glycerol:ethanol solvent (5:1 by volume) was added to the 
mixture, followed by sonication for another 5 min. 
For the fluorescence quenching studies, acrylamide (ACR) was employed at a 
concentration of 1 M, an optimal concentration for such studies (33). 
D. Results and Discussion 
Spectrofluorimetric analysis of native DNA and polynucleotide samples for 
covalent adducts formed with BPDE is complicated by the presence of BP tetraols 
or, more generally, non-covalently linked species which possess pyrene as the 
parent fluorescent chromophore. For the present work it is the tetraol of BPDE 
(referred to hereafter as BPT) that is of concern since it can be produced by 
hydrolysis or photodecomposition of the adducts. To identify interferences from 
BPT it is not sufficient to have only determined the fluorescence spectra of BPT in 
the solvent (glass) of interest. Although a considerable fraction of the BPT in a 
solution containing DNA is isolated by the solvent cage ("free" BPT), BPT also 
forms physical adducts with DNA (34). The differences in the intermolecular 
interactions between BPT and its environment for these two situations are sufficient 
to produce spectral shifts of several nm and differences in vibronic intensity 
distributions. Thus, it is essential to generate standard BPT fluorescence spectra 
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from samples for which BPT has been physically mixed with DNA (or poly-dG) in 
the solvent. 
We have performed such experiments for tetraols from anti-BPDE mixed with 
DNA and poly(dG). Both 77 K laser excited (Sg <— S^) and 4.2 K FLN spectra for 
several excitation wavelengths were obtained and analyzed. In addition, 
fluorescence quenching studies (with ACR) were conducted in order to determine 
the degree of solvent accessibility for different BPT configurations. The results, 
although interesting from physico-chemical and spectroscopic points of view, are 
not central to the present paper and, therefore, are given in the Appendix. That is, 
the spectral features of BPT species shall be viewed here as potential interferences 
in the spectra of covalent adducts. Thus, for what follows, we need only 
summarize the essential findings: there are three BPT species with fluorescence 
origin bands at - 376, 377 and 381 nm; the first two bands are assigned to trans- or 
cis-BPT which are "free" or externally bound to a DNA base while the latter is due, 
at least in part, to quasi-intercalated BPT. All three types of BPT are subject to 
quenching by ACR; the degrees of quenching are discussed in the Appendix. The 
BPT species emitting at 376 and 377 nm are distinguishable from covalent BPDE 
adducts because their origins are significantly blue-shifred relative to those of the 
latter. In addition, these BPT species exhibit relatively narrow fluorescence bands 
in the 77 K spectra. This is not the case for the 381 nm emitting species, which is 
referred to as BPT-381 in what follows, BPT-381 represents a potentially serious 
interference for adducts since it can be easily misassigned to an intercalated 
covalent DNA adduct from (+)-anti-BPDE which exhibits an origin at 381 nm (19). 
This covalent adduct, however, can be differentiated from BPT-381 since its 
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fluorescence is not significantly quenched by ACR. 
1. Preliminary remarks 
The importance of establishing correlations between the moderate and high 
resolution fluorescence spectra of DNA and poly(oligo)nucleotide adducts is 
discussed in the Introduction. To this end, the analyses of laser excited (S2 <- S^) 
77 K and FLN spectra as well as fluorescence quenching data are essential. Table 
n lists the polynucleotides and oligonucleotides whose adducts from (+)-anti-BPDE 
have been studied along with their abbreviations. For example, the alternating 
duplex poly(dG-dC) -poly(dG-dC) is denoted by (dG-dC)2 and the non-altemating 
duplex poly(dG)poly(dC) by (dG)-(dC). It proved important to study the (+)-anti-
BPDE adducts of guanine-monophosphate monomer (GMP) since they are of the 
N^-dG type. 
Table m summarizes the spectral characteristics of the DNA and 
polynucleotide adducts from (+)-anti-BPDE. The results for the first three entries, 
(+)-l DNA, (+)-2 DNA and (+)-3 DNA, are based primarily on our previous work 
(19), cf. Introduction. The peak position of the fluorescence origin band (^^(o.O)) 
and its FWHM provide a good approximation to the energy and width of the 
Sj <— SQ absorption origin for each adduct listed in Table HI. The band positions 
and widths were determined by analysis of the S2 <— excited fluorescence 
spectra, as described elsewhere (19). Following the convention of this reference we 
label the adducts formed from each biomolecular species as (+)-j (j = 1,2, ...) with 
^,(0,0) increasing with increasing j. For adduct assignments based on 77 K spectra, 
only two A^^-values, 346 and 355 nm, were required. The former and latter are 
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quite selective for BPDE-adducts whose are lower or higher than 
~ 379.0 nm, reflectively (19). For example, although the major (+)-l DNA adduct 
from (+)-anti-BPDE (an N^-dG adduct) dominates the fluorescence spectrum for 
= 346 nm, it is a minor contributor to the spectrum obtained with = 355 nm 
(19). The latter spectrum is dominated by the (+)r3 adduct. We hasten to add, 
however, that a complete disentanglement of the spectra from a mixture will often 
require utilization of a fluorescence quencher such as ACR. For example, the 
fluorescence from the minor (+)-2 DNA adduct excited with = 346 nm could 
only be resolved from that of the (+)-l adduct when ACR was used to markedly 
suppress the emission from the latter (19) ((+)-! is an exterior (type 11) adduct and 
is readily accessible to ACR, whereas adducts of type I, such as (+)-2-DNA, are 
relatively less accessible). 
Fluorescence line narrowing spectroscopy provides the ultimate spectral 
resolution for fluorescence-based characterization of biomolecular samples. 
Vibronic linewidths of only a few cm"' are attainable, meaning that detailed 
analysis of both the ground and excited state vibrational modes of the fluorescent 
chromophore is possible. The principles of FLNS for analysis of DNA- and globin-
PAH adducts have been recently reviewed (13). Briefly, the phenomenon of FLN 
is generally observable for narrow line laser excitation of the inhomogeneously 
broadened vibronic absorption bands of the Sj <— absoiption system. A 
reduction in the inhomogeneous broadening contribution to the vibronic 
fluorescence bands of up to two orders of magnitude can be achieved. Either 
origin- or vibronic, (1,0), excitation may be employed. The fomier yields a 
spectrum which contains only information pertaining to the ground state vibrational 
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modes. In contrast, vibronic excitation at different frequencies yields a series of 
spectra which provide the excited state mode frequencies and their relative 
absorption cross-sections. Because the excited state modes are more sensitive than 
- ^ound state modes to substituent and environmental perturbations, vibronically 
excited FLNS is the more selective approach. The reader, who is not famUiar with 
vibronically excited FLNS, may find the following discussion helpful. Let <o^qq^ 
and be the center frequency and inhomogeneous width of the Sj <-
absorption origin. To generate a spectrum characterized by excited state vibrational 
modes in the frequency range = fli ± requires excitation at « ®(0,0) + ^ 
This frequency will generally excite several inhomogeneously broadened and 
overlapping vibronic absorption bands, a, P, ... . The "isochromats" of bands a, p, 
... selected by undergo rapid vibrational relaxation (= 1 picosecond) to their 
respective and energetically distinct positions in the overall distribution 
(inhomogeneous) of the zero-point vibrational level of the state. Subsequently, 
(0,0) fluorescence of the a, P, ... isochromats occurs to produce a multiplet origin 
structure in the » ®(o,o) ^ spectral region, with as many (0,0)-components as 
vibrations excited by (O^^. The differences between the frequencies of these 
components and (0^^ yield the excited state mode frequencies (13, 35, 36). For 
example, to generate excited state modes in the vicinity of 600 cm"^ for the (+)-l 
DNA adduct, cf. Table DI, one would employ a laser excitation wavelength of 
~ 370 nm. An important point is that the multiplet origin structure is located in the 
region of the inhomogeneously broadened fluorescence origin produced under 
non-line narrowing conditions (i.e., S^ <— S^ excitation). 
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2. Synthetic polynucleotide adducts from (+)-anti-BPDE 
The synthetic polynucleotides studied (Table 11) are alternating or 
non-altemating purine-pyrimidine copolymers with backbone conformational 
parameters which place them in the B-DNA class. Since we have found that the 
alternating (dG-dC)2 duplex adducts are most similar to those of DNA we focus on 
their Sg <— Sy excited 77 K and FLN qiectra. Although it has been established that 
the excitation and emission spectra of (±)-anti-BPDE-(dG-dC)2 are heterogeneous in 
nature (30, 37), the improved resolution of the spectra reported here are required 
for definitive distinction between different adduct types'. 
2a. Laser excited (S^ <— S^) fluorescence spectra at 77 K 
Figure 2 shows the 77 K fluorescence spectra for (+)-anti-BPDE-(dG-dC)2 
obtained with = 346 nm (A) and 355 nm (B). The "free" BPT bands at 376.1 
and 376.8 nm bands are absent in spectrum A (cf. Appendix), which exhibits a 
dominant origin at - 377.6 nm (solid arrow) and a shoulder at 381 nm (dashed 
arrow). The shoulder is assigned first. The lower energy excitation at 355 nm 
results in a spectrum (B) for which the shoulder is resolved into the dominant 
origin, i.e., = 355 nm discriminates against the 377.6 nm emitting species. 
Spectrum B is similar to that of BPT-381 {cf. Appendix), for example, the R-ratios 
are 1.34 and 1.36. (The R-ratio is defined as the intensity of the origin band to that 
of the most intense vibronic feature near 400 run (19), cf. Introduction.) 
Furthennore, the 381 nm emitting species of spectrum B (Figure 2) and BPT-381 
are both subject to significant and comparable quenching by ACR. There are other 
similarities, cf. Appendix. Thus, we conclude that the 381 nm emitting species 
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Figure 2. Laser-excited fluorescence spectra of (+)-anti-BPDE-(dG-dC)2 for Xg, = 
346 nm (A) and = 355 iim (B), respectively. The band at 381.1 nin 
coixesponds to quasi-intercalated tetraol. Spectrum C is mainly due to 
the (+)l(dG-dC)2 N^-dG adduct 
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of (+)-anti-BPDE-(dG-dC)2 is BPT-381 and not the (+)-3 adduct formed with DNA, 
vide supra. The latter is not subject to significant quenching and has an R-ratio of 
1.15 (19), Table HI. Furthermore, the (+)-3 adduct, unlike BPT-381 does not 
exhibit fluorescence line narrowing due to strong electron-phonon coupling 
produced by intercalation (19). 
We turn next to the 377.6 nm origin band of Figure 2. Spectrum C of this 
figure is the A-B difference spectrum to which BPT-381 makes a negligible 
contribution. The difference spectrum is due primarily to the covalent adduct 
(+)-l-(dG-dC)2, cf. Table HI. There is also a weak contribution to the spectrum 
from a second adduct, (+)-2-(dG-dC)2. Evidence for this is provided by Figure 3 
which shows the origin-region for (+)-anti-BPDE-(dG-dC)2 in the presence of ACR 
obtained with = 346 nm (A) and 355 nm (B). Comparison of spectrum A with 
spectrum A of Figure 2 (no quencher) shows that ACR significantly quenches 
fluorescence from (+)-l-(dG-dC)2, resulting in the dominance of the fomier by a 
band at = 379 nm (due mainly to (+)-2-(dG-dC)2). Nevertheless, (+)-l-(dG-dC)2 is 
not completely quenched and is responsible for the shoulder at = 377.5 nm (solid 
arrow). Utilization of = 355 nm leads to essentially complete suppression of 
(+)-l-(dG-dC)2 emission and a spectrum (B) from the (+)-2-(dG-dC)2 adduct 
(BPT-381 makes, at most, a weak contribution). Spectrum C is that which when 
added to B, yields A. It is very simil^ to the origin band at 377.6 nm in Figure 2 
and, therefore, is assigned to (+)-l-(dG-dC)2. The S; origins for (+)-l- and 
(+)-2-(dG-dC)2 are at 377.8 and 379.4 nm. These wavelengths are, within 
experimental uncertainty, the same as those for the (+)-l- and (+)-2-DNA adducts, 
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Figure 3. Origin bands of the 77 K laser-excited fluorescence spectra of (+)-anti-
BPDE-(dG-dC)2 in the presence of 1 M ACR, obtained with = 
346 nm (A) and = 355 nm (B), respectively 
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Figure 4. Comparison of FLN spectra of (+)-anti-BPDE-(dG-dC)2 for experimental 
conditions which provide as the major adduct, (+)-! (B) and (+)-2 (A), 
respectively (see also Figure 2). Xg, = 369.6 nm, T = 4.2 K. Zero-
phonon lines are labeled with excited-state vibrational frequencies 
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cf. Table HI. Furthennore, the (+)-2-DNA adduct was also found to be 
significantly less quenchable by ACR than the (+)-l-DNA adduct. 
2b. Laser-excited FLN spectra 
The 4.2 K FLN spectra provide additional support for the above assignments 
of the (+)-l- and (+)-2-(dG-dC)2 adducts. Figure 4 presents spectra obtained with 
= 369.6 nm for (+)-anti-BPDE-(dG-dC)2 in the presence (A) and absence (B) of 
ACR. This wavelength is that which was used to obtain multiplet origin structure 
for (+)-l-DNA in the - 600 cm"^ region (19). Spectrum B is dominated by the 
vibronic line at 579 cm'^. This is also the case for (+)-l-DNA (19). However, the 
higher energy vibrations at 763 and 828 cm"^ are more prominent in spectrum B of 
Figure 4. The reason is that the (+)-2-(dG-dC)2 adduct makes a greater 
contribution to the FLN spectrum. This follows from spectrum A of Figure 4, 
which shows that ACR produces an enhancement in modes at 648, 757 and 
830 cm"^ relative to the mode near 579 cm"^ (now 581 cm"^). Because the 
(+)-l-(dG-dC)2 adduct is more efficiently quenched than (+)-2-(dG-dC)2 and their 
Sj origins are located at 377.8 and 379.4 nm, respectively, we conclude that 
spectrum A is due predominantly to the (+)-2-(dG-dC)2 adduct. In the Appendix, it 
is shown that BPT-381 cannot be contributing appreciably to the 757 and 830 cm"^ 
bands of spectrum A. It is noteworthy that the modes for (+)-l- and 
(+)-2-(dG-dC)2 are identical to those measured for (+)-l- and (+)-2-DNA (19). The 
possibility that the (+)-l-(dG-dC)2 adduct contributes to the 581 cm"' band of 
spectrum A in Figure 4 cannot be excluded since ACR does not completely quench 
its fluorescence. 
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In our studies of BPDE-DNA and BPDE-(dG-dC)2 we have observed what are 
apparently irreversible changes in the fluorescence spectra of samples stored in the 
dark at - 5 °C over a period of several months. Although we have not studied this 
effect in detail, it is clear that aging results in a diminution of fluorescence from the 
(+)-l adducts relative to that from (+)-2 adducts. For example, the R-value for 
(+)-anti-BPDE-DNA obtained with = 346 nm was observed to decrease from 
1.75, Table HI, to 1.3 (with an accompanying red shift of the fluorescence 
spectrum) for one particular sample. Similar behavior was observed for an aged 
(+)-anti-BPDE-(dG-dC)2 sample. These changes might be due to slow 
decomposition of the (+)-l adduct into BPT, which then quasi-intercalates to form 
BPT-381 or, possibly, to conversion of (+)-l into (+)-2 (in the following subsection 
both (+)-l and (+)-2 adducts are assigned to an N^-dG species). An example of the 
effect of aging on a FLN spectrum of (+)-anti-BPDE-(dG-dC)2 is given in Figure 5. 
Spectra A and B were obtained in the absence and presence of ACR (0.5 M) with 
^ex - 356.9 nm. ACR is seen to preferentially quench the 1388, 1442 and 1522 
cm"^ bands. In fact, spectrum B is identical to that of a fresh adducted (dG-dC)2 
sample (not shown) and is due primarily to the (+)-l-(dG-dC)2 adduct. The A-B 
difference spectrum (C) represents the quenched fluorescence spectrum and is 
similar to that of "free" BPT. Thus, decomposition of (+)-anti-BPDE-(dG-dC)2 to 
tetraols has occurred. 
In Figure 5 the broad feature in spectra A and B near 381 nm is due to 
BPT-381 which is subject to quenching, vide supra. Increasing the ACR 
concentration to 1 M led to a further decrease in the intensity of the 381 nm band, 
vide infra. 
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3. Comparison of (+)-anti-BPDE adducts of DNA and polynucleotides 
In this subsection Table m is used for a discussion of the similarities and 
differences between the fluorescence characteristics of the (+)-!-, (+)-2-, and 
(+)-3-DNA adducts and those of adducts formed with (dG-dC)2, (dG)-(dC) and 
(dG). For the sake of brevity, spectra for the latter two polynucleotides have not 
been presented and only a portion of the FLN spectra obtained for (dG-dC)2 are 
shown. The first column of Table m lists the adducts; when more than one adduct 
from the precursor is observed the major adduct is so labeled. Thus, for example, 
(+)-l-DNA and (+)-l-(dG-dC)2 are major adducts. The second and third columns 
provide the wavelength and width of the inhomogeneously broadened fluorescence 
origin, while the fourth column gives the R-value. These parameter values, 
together with the degree of quenchability by ACR, are most important for the above 
comparison. 
From Table HI one observes that all polynucleotides, except (dA-dT)2, yield 
an adduct with a fluorescence origin at ~ 378 nm, a (+)-l adduct. We emphasize 
again, however, that the adducts for each polynucleotide are labeled as (+)-j, with 
increasing j corresponding to increasing A.^(oo). That is, adducts from different 
polynucleotides with the same j-value need not necessarily be the same (chemically 
and/or structurally). Figure 6 gives the FLN spectra for the standard trans isomer 
of the (+)-anti-BPDE-N^-GMP adduct (spectrum C), (+)-l-DNA (spectrum A), 
(+)-anti-BPDE-(dG-dC)2 (spectrum B), (+)-anti-BPDE-(dG)-(dC) (spectrum D) and 
(+)-anti-BPDE-(dG) (spectrum E). All spectra were obtained with = 369.6 nm, 
which is quite highly selective for (+)-l adducts whose Sj state is located at 
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Figure 5. FLN spectra of (+)-anti-BPDE-(dG-dC)2 contaminated with BPT 
obtained without (A) and with quencher (0.5 M ACR) (B). = 
356.9 nm, T = 4.2 K. Spectrum C represents the quenched contribution 
originating mostly from "free" BPT 
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Figure 6. Comparison of FLN spectra: (+)-anti-BPDE-DNA, (+)-l addiict (A); 
(+)-antï-BPDE-(dG-dC)2 (B); trans isomer of (+)-anti-BPDE-N2-GMP 
(C); (+)-anti-BPDE-(dG)-(dC) (D); (+)-anti-BPDE-poly(dG) (E). 
= 369.6 nm, T = 4.2 K 
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- 378 nm. That the spectrum for (+)-l-DNA is dominated by the 579 cm"^ mode 
was established earlier (19). The close similarity of the spectra in Figure 6 
establishes that all adducts are of the N^-dG type. Furthermore, the standard 
spectrum of the cis isomer of (+)-anti-BPDE-N^-GMP is distinctly different from 
that of the trans isomer (spectrum C) (38). Thus, we may conclude that the (+)-l 
adducts are trans isomers, a conclusion consistent with that of earlier work (39). 
We note that the (+)-2 adduct from (dG)-(dC) probably contributes to spectrum D 
since its Sj state is almost degenerate with that of the (+)-l adduct. 
The (+)-l-DNA adduct and the trans isomer of (+)-anti-BPDE-GMP exhibit 
the same R-value of 1.75, Tables m and IV. This result, together with spectra A 
and C of Figure 6, support our earlier assignment (19) for (+)-l-DNA to a type II 
(external) adduct with high quenching efficiency. Inspection of Table HI reveals 
that it is the (+)-l adduct of (dG-dC)2 whose R-value (1.55) and other fluorescence 
characteristics are most similar to those of (+)-l-DNA. For example, the R-values 
for the (+)-l adducts of (dG)<dC) and (dG) are considerably smaller (1.20 and 
1.15), indicating that they correspond to a type I (interior) site (19). Consideration 
of the values given in Table in for the widths of the fluorescence origin bands due 
to inhomogeneous broadening (the linear electron-phonon coupling is weak for all 
(+)-l adducts, as judged by the FLN spectra, and makes only a negligible 
contribution to the bandwidth reveals that the structure of (dG) is highly irregular, 
thereby providing a relatively less ordered environment for the trans (+)-l-N^-dG 
adduct. Coiling of (dG) probably contributes to the heterogeneity. It should also 
be noted that the adducts from (dG)<dC) are distinct from those of DNA and 
(dG-dC)2 in that the (dG)*(dC) (+)-l adduct is less quenchable by ACR than the 
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(+)-2 adduct. Table HI also reveals that it is the (+)-2 adduct of (dG-dC)2 which is 
most similar to (+)-2-DNA. 
Thus, the alternating (dG-dC)2 copolymer affords a structure conducive to the 
formation of two adducts with spectral and other properties which are very similar 
to the (+)-l (type H) and (+)-2 (type I) adducts identified in previous woric (19). 
However, this copolymer does not yield an adduct of the intercalated and 
non-quenchable (+)-3-DNA type with a fluorescence origin at - 381 nm. This 
adduct does not exhibit line narrowing in its fluorescence or excitation spectra due 
to strong electron-phonon coupling (19). In the Appendix it is shown that 
BPT-381, which can be easily mistaken for a covalent adduct of the (+)-3 type, 
does exhibit line narrowing and is quenchable by ACR. Figure 7 compares the 
4,2 K fluorescence q)ectra of (+)-anti-BPDE-DNA and -(dG-dC)2 obtained with 
= 356.9 nm (Sj <— vibronic excitation) and in the presence of 1 M ACR. 
Although fluorescence from the (+)-l adduct is significantly quenched, (+)-l is still 
the major contributor to the sharp vibronic features at 1442, 1519, 1560 and 
1606 cm"^ ((+)-2 is a minor adduct for DNA (19) and (dG-dC)2). The close 
similarity between these features for DNA and (dG-dC)2 further confirms that 
(dG-dC)2 yields an exterior type II adduct of the (+)-l-DNA type. It is, however, 
the broad feature at ~ 381 nm for (+)-anti-BPDE-DNA that is of primary interest, 
spectrum A. It is the fluorescence origin of (+)-3-DNA (19). Spectra obtained 
without ACR (not shown) show that this fluorescence is not quenchable. In 
contrast, (dG-dC)2 emission at 381 nm is quenchable. (The degree of quenching 
for 1 M ACR is higher than for 0.5 M ACR, see Figure 5). Figure 7 and other 
results 
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Figure 7. FLN spectra of (+)-anti-BPDE-DNA (A), and (+)-anti-BPDE-(dG-dC)2 
(B) in the presence of 1 M ACR. = 356.9 nm, T = 4.2 K 
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establish that (dG-dQg does not yield an appreciable amount of an intercalated 
adduct. This is consistent with the finding that the intercalation association 
constant for this duplex is small relative to that of DNA (37, 40). The explanation 
may lie in the fact that DNA has many intercalation binding sites, 10 when strand 
polarity is taken into account. In addition, the reactivities of guanines with 
(+)-anti-BPDE are distinctly non-statistical with respect to sequence (11, 12, 41). 
In summary, all polynucleotides studied yield a (+)-! adduct of the 
trans-N^-dG type whose special characteristics are very similar to those of 
(+)-l-DNA. However, it is the alternating (dG-dC)2 that provides the best model 
for the (+)-l and (+)-2-DNA adducts. The FLN spectra of the (+)-l and -2 
adducts, when compared with those of the standard trans isomer of (+)-anti-BPDE-
GMP, reveal that both are the trans isomer of the N^-dG covalent adduct. As noted 
earlier, the FLN spectra of the cis isomer of (+)-anti-BPDE-GMP are distinct from 
those of the trans isomer. Furthermore, HPLC analysis of the nucleotide adducts 
from (dG-dC)2 and (+)-anti-BPDE has shown that only the trans isomer is formed 
(32). Of course, with this analysis procedure all information pertaining to different 
DNA sites for the same chemical adduct is lost. The present and earlier work (19) 
establishes that the (+)-l adduct for DNA and (dG-dC)2 is of type II or exterior 
(solvent accessible) with a relatively weak interaction between the pyrene 
chromophore and bases. The (+)-2 adduct is characterized by a stronger interaction 
(with concomitant red shift of the S j state) and has a more interior (hydrophobic) 
configuration, albeit not an intercalated configuration as is the case for (+)-3-DNA. 
The chemical structure of the latter is considered later. 
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4. Anti-BPDE adducts of an oligodeoxynucleotide with specific base composition 
According to the above analysis, the (+)-l and (+)-2 adducts of trans-N^-dG 
for DNA and (dG-dC)2 are not of the intercalated type. If this is correct then one 
might expect to observe both adducts for an oligodeoxynucleotide such as 
d(ATATGTATA). On the other hand, an intercalated adduct of the (+)-3-DNA 
type should not be observed. The single strand d("TGT") provides for high 
yields of N^-dG adducts (31). For (+)-anti-BPDE and (-)-BPDE the transicis ratios 
are 7:1 and 2:1, respectively, as determined by HPLC analysis following enzymatic 
digestion (31). Table IV summarizes the spectral characteristics of the trans and 
cis standard isomers of the N^-dG adduct from GMP and the trans and cis isomers 
from d("TGT"). Only spectra for the trans isomers from d("TGT") are 
shown. 
Figure 8 presents 77 K fluorescence spectra for a (+)-anti-BPDE-
deoxynucleotide sample containing only the trans N^-dG adduct (as determined by 
HPLC analysis). Spectra A and B were obtained with = 355 and 346 nm, 
respectively. Only the origin regions are shown. Spectrum A is dominated by an 
origin near 379 nm but exhibits a distinct shoulder at - 377 nm. The latter origin 
dominates the spectrum (B) for = 346 nm (recall that this wavelength is 
optimum for a (+)-l adduct while = 355 nm discriminates against the (+)-l 
adduct (in favor of (+)-2)). Thus, the picture which emerges is very similar to that 
seen earlier for DNA and (dG-dC)^. Straightforward deconvolution leads to the 
assignment of two covalent adducts with fluorescence origins at 377.6 and 
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Figure 8. A comparison of 77 K laser-excited fluorescence spectra of (+)-anti-
fra/i5-BPDE-d(ATATGTATA) for = 355 nm (A) and 346 nm (B) 
with spectrum of trans isomer (+)-anti-BPDE-GMP (C), obtained with 
= 355 nm 
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379.6 nm, Table IV. These wavelengths are essentially identical to those for the 
(+)-l and (+)-2 adducts of DNA and (dG-dC)2, Table n. Only one trans N^-dG 
adduct is observed from GMP, spectrum C of Figure 8. Its origin is slightly blue 
shifted relative to 377.6 nm and is slightly contaminated by BPT, which gives rise 
to a barely discernible low energy shoulder. 
The covalent adducts from d(-TGT") are prone to very slow decomposition 
into tetraols. Figure 9 presents FLN spectra obtained with = 356.9 nm for a 
fresh sample (A) and partly decomposed (B) sample. These spectra should be 
compared with those of Figure 7, from which it may be concluded that spectrum A 
of Figure 9 exhibits narrow vibronic features (1388-1603 cm"^) which are 
essentially identical to those of (+)-anti-BPDE-DNA and -(dG-dC)2 due primarily to 
the dominant (+)-l adduct. A striking difference between the spectra of Figures 7 
and 9 is the absence of the broad ~ 381 nm emission in the latter. Thus the (+)-3 
adduct or BPT-381, as the case may be, are. absent for the deoxyoligonucleotide. 
Returning to the tetraol contaminated spectrum (B) of Figure 9, we note that our 
standard FLN ^ectra establish that the increased intensities of the lower frequency 
modes (e.g., 1443 cm"') relative to the 1560 cm"' mode is entirely consistent with 
fluorescence from "free" BPT. 
Comparison of the R-values of 1.55 and 1.3 for the 377.6 and 379.6 nm trans 
adducts of d("TGT") (referred to hereafter as A and B) with those of the (+)-l 
and (+)-2 adducts of DNA and (dG-dC)2, Table HI, provides additional support for 
strong correlations. The A and B conformations are actually quite stable. Heating 
to 80 °C or prolonged laser irradiation at 355 nm did not lead to significant 
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Figure 9. Comparison of FLN spectrum of (+)-anti-trans-BPDE-d(ATATGTATA) 
adducts (A) with that from a decomposed sample (B), = 356.9 nm, 
T = 4.2 K 
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changes in the low temperature fluorescence spectra. However, heating to 80 °C 
produced a significant blue shift of the absorption. Upon subsequent 
cooling to room temperature the original absorption spectrum was recovered. This 
suggests that the A and B conformations of the trans N^-dG adduct may be of the 
base-base stacking type since stacking interactions can be disrupted at higher 
temperatures. 
The results of this sub-section indicate that the A and B conformations of the 
trans N^-dG adduct from d("TGT") are very similar to those for the (+)-l and 
-2 adducts of DNA and (dG-dC)2 and provide strong support for the analysis 
procedure utilized in the earlier sub-sections and work (19). 
5. Assignment of a (+)-anti-BPDE-deoxyadenosine adduct of DNA 
As discussed in the Introduction, (-)-anti-BPDE yields a more heterogeneous 
distribution of DNA adducts than (+)-anti-BPDE which consists of 5 covalent 
adducts, (-)-j (j = 1-5). Although the relative levels of (-)-j (j = 1-3) differ 
significantly from those of (+)-j (j = 1-3), the spectral and quenching characteristics 
of the adducts with the same j-level are identical. It was suggested that (19) the 
(-)-4 adduct could be associated with a base other than guanine, for example, 
adenine, since its ^,(o,o) 382.7 nm is higher than those of (-)-j (j = 1-3) and, yet, 
the adduct is of type II. Osborne et al. (26) and Brookes and Osborne (27) have 
reported that (+)- and (-)-BPDE-DNA consists of 2% and 18% of N^-dA adducts, 
respectively, which could explain why the (+)-4 adduct could not be detected (19). 
In an attempt to identify this minor adduct studies of (+)-anti-BPDE-(dA-dT)2 were 
undertaken. First, the results from 77 K fluorescence studies summarized in Table 
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m show, as expected, that the (+)-l and (+)-2 from dG are absent. Only one 
adduct with a fluorescence origin at 382.5-383.0 nm was identified and is of type . 
n. These characteristics are identical to those of (-)-4-DNA. 
Figure 10 compares the FLN spectra of (+)-anti-BPDE-DNA (A) and (+)-anti-
BPDE-(dA-dT) (B) obtained with = 374.2 nm. This wavelength was chosen to 
reveal mode structure in the 600 cm"^ region for adducts with a fluorescence origin 
near 382 nm. The spectra exhibit the same modes, for example, 472 and 585 cm'\ 
The latter is the counterpart of the 579 cm"' mode of the (+)-l and -2 adducts. The 
frequency shift of 6 cm"^ is large and, by itself, could be used to distinguish 
between N^-dG and N^-dA adducts of BPDE. However, the vibronic intensity 
distributions of spectra A and B in Figure 10 are different. Two possible 
explanations for this are that (+)-2-DNA makes a significant contribution to the 
472 cm"' band of spectrum A and that the trans to cis distributions for DNA and 
(dA-dT)2 are different. The FLN spectrum for (-)-4-DNA is similar to those of 
Figure 10. The FLN data indicate that the (+)-4 and (-)-4 adducts possess the same 
chemical stracture and, furthermore, that they are not N^-dG adducts. Consistent 
with the results of Osborne et al. (26), we have observed a much higher relative 
signal strength from (-)-4-DNA than from (+)-4-DNA. On the basis of their work 
it is not reasonable to assign both adducts as N^-dA. The structures of the trans 
isomer of this adduct and N^-dG are shown in Figure 11. 
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Figure 10. Comparison of FLN spectra: (+)-anti-BPDE-DNA (A) and (+)-anti-
BPDE-(dA-dT)2. = 374.2 nm, T = 4,2 K 
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Figure 11. Structures of the N^-dG (2-NH2) (A), and N®-dA (6-NH2) (B) adducts 
formed from (+)-anti-BPDE 
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E. Conclusions and Further Discussion 
This work shows that FLNS in combination with fluorescence quenching and 
laser excited S2 <— fluorescence spectroscopy can distinguish between chemically 
and/or structurally (site) different adducts of BPDE in the distribution of adducts 
from a polynucleotide. Furthermore, differences in the type and heterogeneity of 
distributions from different polynucleotides and single strand oligonucleotides can 
be detected. By themselves the results establish that the major DNA adduct from 
the stereoselective reaction with (+)-anti-BPDE (~ 85%) is the trans isomer of 
N^-dG, which is in accord with previous work (39). The (+)-2-DNA is also an 
N^-dG adduct which is suggested to be the same stereoisomer in a different site 
configuration. The (+)-3-DNA adduct also involves binding to dG and this, 
together with the results of other workers (26, 27), indicate that it is probably 
intercalated 0®-dG. A fourth, very minor adduct ((+)-4-DNA) was observed and 
assigned as N^-dA. It should be noted that the major (+)-l-DNA adduct does not 
appear to be responsible for the high mutagenic activity of (+)-anti-BPDE (27, 42). 
It has been shown, for example, that 36% of the activation of the ras protoncogene 
in vitro by (+)-anti-BPDE occurs at the adenine residue (43), despite the latter's 
low reactivity. Therefore, the characterization and determination of minor stable 
adducts and labile adducts which undergo elimination (e.g., the alkali labile N^-dG 
adduct (11, 12, 41)) is very important (26, 27, 42, 43). 
In this work only three polynucleotide duplexes ((dG-dC)2, (dGXdC), 
(dA-dT)^) were studied and of these it is the alternating (dG-dQj that yields (+)-l 
and -2 adducts which are most similar to the trans N^-dG adducts of DNA. 
However, the R-ratio for (+)-l-(dG-dC)2 of 1.55 is somewhat lower than the value 
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of 1,75 for (+)-l.DNA. Since (dG)-(dC) and d(ATATGTATA) yield an N^-dG 
adduct with spectral properties similar to those of (+)-l-DNA and dG tracts have 
been found to be particularly conducive to reactions of (+)-anti-BPDE with dG (11, 
12, 31, 41) it is most likely that in native DNA more than one type of base-triplet 
involving dG contributes to the (+)-l-DNA fluorescence. This is probably also the 
case for (+)-2 and -3-DNA. The (dG-dC)2 duplex, however, does not yield an 
adduct with the spectral properties of (+)-3-DNA. The only duplex that does is 
(dGXdC) and so it is possible that a dG tract is important for the formation of the 
(+)-3 intercalated adduct. 
Although our results for the adducts from (-)-anti-BPDE with the above 
polynucleotides have not been presented, they support our finding that the laser 
excited S2 <— fluorescence spectra, FLN spectra and quenching properties of the 
(+)-j-DNA and (-)-j-DNA adducts with the same j-value (j = 1-4) are exceedingly 
similar (only the distributions differ). Since we have shown that the trans and cis 
isomers of the N^-dG adduct with GMP are readily distinguishable by FLNS, the 
above close similarity suggests that (+)-j-DNA and (-)-j-DNA are enantiomeric 
pairs, cf. Figure 2. Distinction between the two enantiomers would depend, in 
part, on interactions with chiral centers of neighboring bases which, if weak, would 
not allow for distinction by FLNS. We note that we have shown that the (+)- and 
(-)-anti-BPDE-DNA adducts can be distinguished from those from racemic syn-
BPDE by FLNS (20). 
Although (+)- and (-)- anti-BPDE form stable adducts, the former is 
significantly more mutagenic for the same total adduction (stable) level in repair-
competent cells (1, 27). Both are comparably mutagenic in the repair deficient 
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Salmonella typhimurium strain (44). Our results provide a more detailed picture of 
the differences in the adduct distributions from (+)- and (-)-anti-BPDE but the 
different mutagenic activities of the two enantiomeric forms cannot be understood 
in terms of the adduct (stable) distributions without invoking unique site structural 
properties of the (+)-j and (-)-j adducts (6, 42, 43). However, if one is to hold to 
the assumption that it is the diol epoxide metabolic pathways of BaP which, in vivo, 
lead to mutagenesis and tumorigenesis than the roles of labile adducts and (+) and 
(-)-syn-BPDE must be more carefully assessed. In addition, the possibility that the 
radical cation (one-electron oxidation) metabolic pathway may be important for 
mutagenesis and carcinogenesis is now distinct (8, 25). 
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G. Appendix: Physical Mixtures of Anti-BPT with Native DNA and (dG) 
Figure A1 shows 77 K laser-excited (Sg <— §) spectra of racemic anti-BPT 
(6 X 10"® M) which has been physically mixed with DNA (10'^ M). Spectrum A 
and B were obtained in the absence and presence of the fluorescence quencher 
(ACR, 1 M) with = 355 nm. The former is characterized by three origins at 
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~ 376.1, 376.8, and 381.1 nm. Utilization of = 346 nm yielded a spectrum (not 
shown) that is dominated by the BPT responsible for the 376.1 and 376.8 nm 
bands. These two bands are assigned to "free" and/or weakly physically bound (to 
DNA) BPT. Spectrum C (dashed) in Figure A1 is the A-B difference spectrum 
which illustrates (as does a comparison of spectra A and B) that with 1 M ACR the 
381.1 nm fluorescence is almost entirely quenched (considerably more so than the 
"free" BPT bands; the 376.1 nm band is more efficiently quenched than the 376.8 
nm band). Since these are low temperature glass spectra, it is clear that the 
observed quenchings are of the static type dictated by frozen in configurations of 
ACR-BPT-DNA which exist at room temperature. The 381.1 nm band is referred 
to as BPT-381. BPT-381 and "free" BPT was also observed for a physical mixture 
of poly (dG) and DNA. The significant red shift of the Sj state energy of BPT for 
the BPT-381 entity indicates that in the latter the pyrenyl chromophore is strongly 
interacting with nucleic acid bases, for example, base-base stacking interaction. Yet 
the structure of the physically bound BPT is sufficiently open to permit solvent 
accessibility, i.e., ACR quenching. At sufficiently high laser intensity (- 30 
mW/cm^) it was observed that the fluorescence intensity of BPT-381 relative to that 
of the "free" BPT bands increased, suggesting the possibility that BPT-381 could be 
contributed to by a photoproduct or that interconversion in the excited state between 
the "free" BPT and BPT-381 is occurring. 
FLN spectra of BPT-DNA and BPT-(dG) were also obtained. As an example, 
Figure A2 shows spectra for the BPT-DNA mixture obtained with = 369.6 nm 
in the absence (A) and presence (B) of ACR. The sharp zero-phonon lines (ZPL) 
are labeled with the Sj state vibrational frequencies since the ZPL for "free" BPT 
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and BPT-381 should be centered near 376-377 nm and 381 nm, respectively, 
comparison of FLN spectra A and B and the results of Figure A1 establish that the 
763 and 830 cm'^ ZPL are due to BPT-381 while the lower frequency modes, for 
example, 469 and 579 cm'\ are due to "free" BPT. 
As discussed in the main body of the text, BPT-381 can be easily misassigned 
to the (+)-3-DNA type I adduct. However, the latter is distinct in that its strong 
linear electron-phonon coupling precludes the observation of line narrowing (of the 
type observed for BPT-381) and its fluorescence is not significantly quenched by 
ACR. 
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Figure Al. Laser-excited fluorescence spectra: racemic BPT-DNA (A) and racemic 
BPT-DNA + 1 M ACR (B). = 355 nm and T = 77 K. Spectrum C 
is the difference between A and B which identifies the ACR-quenched 
bands 
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Figure A2. FLN spectra of (+)-anti-BPT+DNA obtained for vibronic excitation: 
without (A) and with quencher (1 M ACR) (B). = 369.6 nm, 
T = 4.2 K 
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Tablé I. Spectral characteristic of (+)- and (-)-BPDE-DNA adducts at 
T = 77 K 
(+) adducts (-) adducts 
fluorescence 
band max, 
nm 
site 
type 
fluorescence 
band max, 
nm 
site 
type 
(+)-l 378.0 n (-)-i 378.0 n 
(+)-2 379.3 (-)-2 379.3 I» 
(+)-3 380.6 I (-)-3 380.6 I 
(-)-4 382.7 u 
(-)-5 385.2 n 
® We assign (+)-2 and (-)-2 as site I type adducts with a "degree" of 
interior binding that is less than that for (+)-3 and (-)-3. 
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Table H. Biomolecules used in adduction experiments with (+)-anti-BPDE 
Biomolecule - Abbreviation 
Adduct 
concentration® 
(M) 
poly (dG-dC)-poly (dG-dC) 
poly (dA-dT)'poly (dA-dT) 
poly (dG)'poIy (dC) 
poly (dG) 
(dG-dC)2 
(dA-dT): 
(dG)idC) 
(dG) 
- 10* 
guanine-monophosphate GMP frans - 10'® 
as - 10 ? 
d(ATATGTATA) 
oligonucleotide 
(..TGT..) trans ~ 10"® 
cis ~ 2 X 10"^ 
calf thymus DNA DNA -  1 0 ®  
® At 20 mM sodium cacodylate buffer, 20 mM NaCl, pH 7.0. 
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Table in. Spectral characteristic of (+)anti-BPDE covalent adducts 
Adducts 
J
î
 
FWHM 
(0.0) 
(cm"') 
R Site 
type 
Quenchable 
by ACR 
(+)-lDNA" 378.0 190 1.75 n yes 
(+)-2DNA 379.3 180 1.25 lb yes^ 
(+)-3DNA 380.6 340 1.15 I no 
(+)-4DNA 382.7 -200 .... n yes 
(+)-l(dG-dC)^ 377.6 180 1.55 n yes 
(+)-2(dG-dC) 379.4 200 1.25 i" 
(+)-l(dG)-(dC) 377.9 
with ACR 
210 1.2 I yes, less 
than (+)2 
(+)-2(dG)-(dC)® 
(+)-3(dG)-(dC) 
378.3 
380.5 
230 
-250 
1.35 
1.1 
r 
I 
yes, more 
than (+)1 
no 
(+)-4(dA-dT) -382.5 -200 ---- n yes 
(+)-IpoIy(dG) 378.5 270 1.15 I yes 
(+)-2poly(dG)° 379.3 300 1.0 I" yes 
(+)-3poly(dG) 380.5 340 1.1 I slightly 
° Major adduct. 
^ We assign (+)2 as site I type adducts with a "degree" of 
interior binding (and/or stacking interactions between the DNA bases and 
the pyrenyl residues) that is less than that for (+)3. 
^ But less than (+)1, 
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Table IV. Spectral characteristics of (+)anti-BPDE-GMP and (+)anti-BPDE 
d(ATATGTATA) adducts 
Adducts of 
(+)-anti BPDE 
(0,0) band max 
(nm) 
± 0.1 nm 
FWHM" 
(0,0)(cm'b 
R 
(± 0.05) 
Site 
type 
N^-dG 
rron^-GMP 377.3" 130 1.75 .. 
N^-dG 
cw-GMP 377.4^ 150 1.75 
N^-dG 379.6'' 250 1.3 I 
ft'ans-d(..TGT..) 377.6® 200 1.55 n 
N^-dG 379.4 190 1.25 I 
cw-d(..TGT..) 377.4® 200 1.6 n 
377.2 140 -1.85 u 
° Band maxima and width of (0,0) fluorescence bands were obtained after 
deconvolution. 
^ FWHM was calculated as a twice the half-width on the high energy side. 
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